<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">58215</article-id><article-id pub-id-type="doi">10.7554/eLife.58215</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Short Report</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Stem cell regionalization during olfactory bulb neurogenesis depends on regulatory interactions between <italic>Vax1</italic> and <italic>Pax6</italic></article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-72167"><name><surname>Coré</surname><given-names>Nathalie</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3865-4539</contrib-id><email>nathalie.core@univ-amu.fr</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-186010"><name><surname>Erni</surname><given-names>Andrea</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund12"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-186012"><name><surname>Hoffmann</surname><given-names>Hanne M</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund11"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-186011"><name><surname>Mellon</surname><given-names>Pamela L</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund9"/><xref ref-type="other" rid="fund10"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-13365"><name><surname>Saurin</surname><given-names>Andrew J</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-186009"><name><surname>Beclin</surname><given-names>Christophe</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-69775"><name><surname>Cremer</surname><given-names>Harold</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8673-5176</contrib-id><email>harold.cremer@univ-amu.fr</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Aix Marseille Univ, CNRS, IBDM, Campus de Luminy</institution><addr-line><named-content content-type="city">Marseille</named-content></addr-line><country>France</country></aff><aff id="aff2"><label>2</label><institution>Department of Obstetrics, Gynecology, and Reproductive Sciences and the Center for Reproductive Science and Medicine, University of California, San Diego</institution><addr-line><named-content content-type="city">San Diego</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Liberles</surname><given-names>Stephen</given-names></name><role>Reviewing Editor</role><aff><institution>Harvard Medical School</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Westbrook</surname><given-names>Gary L</given-names></name><role>Senior Editor</role><aff><institution>Oregon Health and Science University</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>07</day><month>08</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e58215</elocation-id><history><date date-type="received" iso-8601-date="2020-04-24"><day>24</day><month>04</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-08-06"><day>06</day><month>08</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Coré et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Coré et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-58215-v2.pdf"/><abstract><p>Different subtypes of interneurons, destined for the olfactory bulb, are continuously generated by neural stem cells located in the ventricular and subventricular zones along the lateral forebrain ventricles of mice. Neuronal identity in the olfactory bulb depends on the existence of defined microdomains of pre-determined neural stem cells along the ventricle walls. The molecular mechanisms underlying positional identity of these neural stem cells are poorly understood. Here, we show that the transcription factor Vax1 controls the production of two specific neuronal subtypes. First, it is directly necessary to generate Calbindin expressing interneurons from ventro-lateral progenitors. Second, it represses the generation of dopaminergic neurons by dorsolateral progenitors through inhibition of Pax6 expression. We present data indicating that this repression occurs, at least in part, via activation of microRNA miR-7.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>postnatal neurogenesis</kwd><kwd>regulatory interactions</kwd><kwd>olfactory bulb interneurons</kwd><kwd>neural stem cells</kwd><kwd>transcription factors</kwd><kwd>miRNA</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>13-BSV4-0013</award-id><principal-award-recipient><name><surname>Coré</surname><given-names>Nathalie</given-names></name><name><surname>Béclin</surname><given-names>Christophe</given-names></name><name><surname>Cremer</surname><given-names>Harold</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>17-CE16-0025</award-id><principal-award-recipient><name><surname>Coré</surname><given-names>Nathalie</given-names></name><name><surname>Béclin</surname><given-names>Christophe</given-names></name><name><surname>Cremer</surname><given-names>Harold</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004431</institution-id><institution>Fondation de France</institution></institution-wrap></funding-source><award-id>FDF70959</award-id><principal-award-recipient><name><surname>Coré</surname><given-names>Nathalie</given-names></name><name><surname>Béclin</surname><given-names>Christophe</given-names></name><name><surname>Cremer</surname><given-names>Harold</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002915</institution-id><institution>Fondation pour la Recherche Médicale</institution></institution-wrap></funding-source><award-id>EQU201903007806</award-id><principal-award-recipient><name><surname>Coré</surname><given-names>Nathalie</given-names></name><name><surname>Béclin</surname><given-names>Christophe</given-names></name><name><surname>Cremer</surname><given-names>Harold</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>P50 HD12303</award-id><principal-award-recipient><name><surname>Mellon</surname><given-names>Pamela L</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01 HD072754</award-id><principal-award-recipient><name><surname>Mellon</surname><given-names>Pamela L</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01 HD082567</award-id><principal-award-recipient><name><surname>Mellon</surname><given-names>Pamela L</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>P30 CA23100</award-id><principal-award-recipient><name><surname>Mellon</surname><given-names>Pamela L</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>P30 DK063491</award-id><principal-award-recipient><name><surname>Mellon</surname><given-names>Pamela L</given-names></name></principal-award-recipient></award-group><award-group id="fund10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>P42 ES010337</award-id><principal-award-recipient><name><surname>Mellon</surname><given-names>Pamela L</given-names></name></principal-award-recipient></award-group><award-group id="fund11"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>K99 HD084759</award-id><principal-award-recipient><name><surname>Hoffmann</surname><given-names>Hanne M</given-names></name></principal-award-recipient></award-group><award-group id="fund12"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001711</institution-id><institution>Swiss National Science Foundation</institution></institution-wrap></funding-source><award-id>P2BSP3_175013</award-id><principal-award-recipient><name><surname>Erni</surname><given-names>Andrea</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Vax1 suppresses dopaminergic neuron phenotype by inhibiting Pax6 expression in the subventricular zone of the lateral ventricle and is necessary to generate Calbindin interneurons for the postnatal olfactory bulb.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>In the postnatal and adult rodent forebrain, new interneuron precursors are continuously generated by neural stem cell populations along the walls of the lateral ventricles. After their amplification in the subventricular zone (SVZ) and long-distance migration via the rostral migratory stream (RMS) they are added to the preexisting circuitry of the olfactory bulb (OB) (<xref ref-type="bibr" rid="bib2">Alvarez-Buylla and Garcia-Verdugo, 2002</xref>; <xref ref-type="bibr" rid="bib47">Whitman and Greer, 2009</xref>; <xref ref-type="bibr" rid="bib35">Platel et al., 2019</xref>).</p><p>OB interneurons produced in this SVZ-RMS-OB neurogenic system show a wide spectrum of phenotypic diversity at the levels of morphology, terminal position, connectivity, and neurotransmitter use (<xref ref-type="bibr" rid="bib46">Whitman and Greer, 2007</xref>). Lineage studies demonstrated that this diversity relies on the existence of defined microdomains of predetermined neural stem cells in the ventricular-subventricular zone [V-SVZ (<xref ref-type="bibr" rid="bib31">Merkle et al., 2007</xref>; <xref ref-type="bibr" rid="bib44">Ventura and Goldman, 2007</xref>; <xref ref-type="bibr" rid="bib27">Lledo et al., 2008</xref>; <xref ref-type="bibr" rid="bib15">Fiorelli et al., 2015</xref>; <xref ref-type="bibr" rid="bib9">Chaker et al., 2016</xref>)].</p><p>A key question concerns the molecular mechanisms underlying this diversity. It has been shown that Gli1 activation by Sonic Hedgehog (SHH) is necessary to generate Calbindin-expressing periglomerular neurons (CB-N) in the ventral aspect of the ventricular wall (<xref ref-type="bibr" rid="bib23">Ihrie et al., 2011</xref>). Moreover, the zinc-finger transcription factors (TF) Zic1 and Zic2 act as inducers of Calretinin (CR)-expressing GABAergic interneurons in the dorso-septal region (<xref ref-type="bibr" rid="bib43">Tiveron et al., 2017</xref>). However, the high diversity of the postnatal generated interneuron subtypes suggests that more complex molecular cascades and cross regulatory interactions are put in place to define the stem cell compartment at the necessary resolution.</p><p>This is exemplified by the regulation of a group of OB interneurons that, in addition to GABA, use dopamine as their main neurotransmitter (DA-N). This neuron type is generated by neural stem cells located in the dorsal and dorso-lateral aspects of the ventricular wall. Pax6 is a key determinant of this cell type (<xref ref-type="bibr" rid="bib19">Hack et al., 2005</xref>; <xref ref-type="bibr" rid="bib25">Kohwi et al., 2005</xref>) and is expressed in the entire lineage from stem cells to neurons (<xref ref-type="bibr" rid="bib19">Hack et al., 2005</xref>; <xref ref-type="bibr" rid="bib12">de Chevigny et al., 2012b</xref>). In addition to this positive transcriptional regulation, post-transcriptional mechanisms have been shown to be crucial for the negatively control of DA-N production. Indeed, <italic>Pax6</italic> mRNA expression in the postnatal ventricular wall is not restricted to the DA-N producing dorsal progenitor pool, but extends far into the lateral region where other cell types, including purely GABAergic granule cells and CB-N, are produced. However, the presence of the microRNA miR-7 in a Pax6-opposing ventro-dorsal gradient precludes <italic>Pax6</italic> mRNA translation and restricts protein expression, and consequently DA-N phenotype, to the dorsal region (<xref ref-type="bibr" rid="bib11">de Chevigny et al., 2012a</xref>). Thus, complex molecular events implicating transcriptional and post-transcriptional control mechanisms underlie the functional diversity of OB interneurons.</p><p>The Ventral Homeodomain Protein 1 (Vax1), an intracellular mediator of SHH signaling, is expressed in ventral territories of the developing mouse forebrain as well as in ventral aspects of the developing eye (<xref ref-type="bibr" rid="bib21">Hallonet et al., 1999</xref>; <xref ref-type="bibr" rid="bib34">Ohsaki et al., 1999</xref>). In both systems, the expression pattern of <italic>Vax1</italic> is complementary to that of <italic>Pax6</italic>, and genetic studies provided evidence for cross regulatory interactions between both factors (<xref ref-type="bibr" rid="bib20">Hallonet et al., 1998</xref>; <xref ref-type="bibr" rid="bib6">Bertuzzi et al., 1999</xref>; <xref ref-type="bibr" rid="bib21">Hallonet et al., 1999</xref>; <xref ref-type="bibr" rid="bib39">Stoykova et al., 2000</xref>; <xref ref-type="bibr" rid="bib5">Bäumer et al., 2002</xref>; <xref ref-type="bibr" rid="bib33">Mui et al., 2005</xref>).</p><p>At embryonic stages, constitutive <italic>Vax1</italic> mutants show a strong decrease in GABAergic interneurons in the developing neocortex, indicating an essential function in their generation (<xref ref-type="bibr" rid="bib40">Taglialatela et al., 2004</xref>). <italic>Vax-1</italic> homozygous mutants die generally at perinatal stages and only few ‘escapers’ survive for a few weeks after birth. In these animals, the entire postnatal SVZ-RMS-OB neurogenic system is severely compromised, showing accumulation of precursors in the SVZ and severe disorganization of the RMS (<xref ref-type="bibr" rid="bib38">Soria et al., 2004</xref>), altogether precluding a detailed analysis of Vax1-function at later stages.</p><p>In an attempt to understand the regulatory cascades underlying postnatal OB interneuron diversity, we identified <italic>Vax1</italic> as a potential candidate. Indeed, based on a high-resolution gene expression screen, comparing the postnatal pallial and subpallial OB lineages, we found that <italic>Vax1</italic> mRNA is present in a ventro-dorsal gradient along the lateral wall of the forebrain ventricles. Functional studies using conditional mutants demonstrate that Vax1 is essential for the generation of CB-N by the ventral stem cell pool. Moreover, we show that Vax1 acts as negative regulator of DA-N OB fate via downregulation of the pro-dopaminergic factor Pax6. Finally, we provide data suggesting that this repressor function is, at least in part, mediated by induction of miR-7.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title><italic>Vax1</italic> is expressed in a ventro-dorsal gradient along the lateral ventricle</title><p>We investigated gene expression during postnatal OB neurogenesis by in vivo electroporation of neural stem cells in the lateral and dorsal aspects of the forebrain lateral ventricle at postnatal day 1 (P1), followed by the isolation of homotypic cohorts at different time points by microdissection and FACS. Microarray analyses provided detailed insight into gene expression changes between the two neurogenic lineages (‘in space’) and during the progression from stem cells to young neurons (‘in time’; <xref ref-type="fig" rid="fig1">Figure 1A</xref>; for detail see <xref ref-type="bibr" rid="bib43">Tiveron et al., 2017</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title><italic>Vax1</italic> is expressed in the lateral V-SVZ.</title><p>(<bold>A</bold>) Representation of the strategy used for transcriptomic analysis in time and space in the dorsal and lateral OB lineages. pCX-GFP plasmid was introduced into neural stem cells (NSCs) residing within the dorsal or lateral V-SVZ and GFP-positive cells were isolated by FACS at different time points after electroporation (Elpo). The mRNA content was analyzed by micro-array (<xref ref-type="bibr" rid="bib43">Tiveron et al., 2017</xref>). (<bold>B</bold>) Quantification of <italic>Vax1</italic> mRNA expression detected by micro-array analysis in dorsal (brown) and lateral (purple) progenies during neurogenesis. (<bold>C–H</bold>) In situ hybridization revealing <italic>Vax1</italic> mRNA (in blue) combined with immuno-histochemistry using antibodies detecting (in brown) PAX6 (<bold>C, C’, G</bold>), ASCL1 (<bold>D, D’</bold>), DLX2 (<bold>E, E’, H</bold>) or KI67 (<bold>F, F’</bold>) proteins in the V-SVZ (<bold>C–F</bold>) or RMS (<bold>G, H</bold>) at postnatal day 3 (<bold>P3</bold>). (<bold>C’–F’</bold>) High magnification of cellular staining in the V-SVZ (area indicated by the yellow bracket in C-F). Arrows (<bold>C’</bold>): examples of strong PAX6 only positive cell in the dorso-lateral SVZ; blue staining underneath labels cells from a distinct plane. Arrow heads (<bold>E’, F’</bold>): double positive cells for DLX2 and KI67, respectively. High magnification of the RMS highlights the differential expression of <italic>Vax1</italic> and Pax6 along the dorso-ventral axis (<bold>G’,G”</bold>) and the co-localization with Dlx2 (<bold>H’,H”</bold>). (<bold>I</bold>) Schematic representation of gene expression profile in different cell types of the neurogenic sequence. Circular arrow indicates proliferating cells. LV: lateral ventricle, RG: radial glia, TAP: transit amplified precursor, VZ: ventricular zone, SVZ: sub-ventricular zone. D: dorsal, L: lateral, S: septal, V: ventral. Scale bars: 100 µm (<bold>C–F</bold>), 20 µm (<bold>C’–F’</bold>), 50 µm (<bold>G–H</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58215-fig1-v2.tif"/></fig><p>These analyses showed that <italic>Vax1</italic> was confined to the neurogenic lineage derived from the lateral ventricular wall (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). <italic>Vax1</italic> mRNA was induced at low levels at 1 day post-electroporation (dpe) when most GFP-positive cells were transit amplifying precursors [<xref ref-type="bibr" rid="bib7">Boutin et al., 2008</xref>; <xref ref-type="fig" rid="fig1">Figure 1B</xref>]. Expression strongly increased at 2dpe and remained stably high at 4dpe, when most cells were migratory neuronal precursors, before steeply decreasing at 7dpe when cells arrived in the OB and emigrated from the RMS to invade the granule cell (GCL) and the glomerular (GL) layers (<xref ref-type="bibr" rid="bib43">Tiveron et al., 2017</xref>). In comparison, isolates from dorsally electroporated brains showed no obvious <italic>Vax1</italic> mRNA expression over all analyzed time points (<xref ref-type="fig" rid="fig1">Figure 1B</xref>).</p><p>Next, we investigated <italic>Vax1</italic> co-expression with known markers of defined neuronal subsets or differentiation stages in the postnatal V-SVZ. In the absence of a Vax1 antibody that provided reliable signals on postnatal tissue sections, we combined in situ hybridization for <italic>Vax1</italic> mRNA with immunohistochemistry for the proteins PAX6, ASCL1, KI67, and DLX2 (<xref ref-type="fig" rid="fig1">Figure 1C–H</xref>). <italic>Vax1</italic> mRNA always showed a gradient-like distribution along the lateral ventricular wall, with highest expression in the ventral-most aspect and extending far into dorsal regions (<xref ref-type="fig" rid="fig1">Figure 1C,D,E,F</xref>). Fainter expression was observed along the septal wall. In the lateral wall, <italic>Vax1</italic> mRNA was excluded from the VZ but expressed in the underlying SVZ (<xref ref-type="fig" rid="fig1">Figure 1C’,D’,E’,F’</xref>). <italic>Vax1</italic> mRNA in the lateral wall was generally non-overlapping with PAX6, a marker for the dorsal stem cell pool and a determinant for the DA-N lineage (Figure C,C’). <italic>Vax1</italic> mRNA-positive cells rarely expressed ASCL1 (3.3%±0.32), a marker for transit amplifying precursors (<xref ref-type="fig" rid="fig1">Figure 1D,D’</xref>), but the vast majority was labeled with a DLX2 antibody (90%±0.89) (<xref ref-type="fig" rid="fig1">Figure 1E,E’</xref>; arrowheads), confirming the preferential expression of <italic>Vax1</italic> in migratory neuronal precursors (<xref ref-type="bibr" rid="bib13">Doetsch et al., 2002</xref>; <xref ref-type="fig" rid="fig1">Figure 1I</xref>). Finally, about one third (32.6%±3.07) of the <italic>Vax1</italic>+ cells in the SVZ expressed the proliferation marker KI67 (<xref ref-type="fig" rid="fig1">Figure 1F,F’</xref>, arrowheads), likely representing mitotic neuroblasts. In the RMS, <italic>Vax1</italic> mRNA was also present in a ventro-dorsal gradient, complementary to PAX6 immunostaining (<xref ref-type="fig" rid="fig1">Figure 1G</xref>), although this organization was less evident than in the SVZ, probably due to cell intermingling in this migratory compartment (<xref ref-type="fig" rid="fig1">Figure 1G’, G”</xref>). Like in the SVZ, <italic>Vax1</italic> mRNA in the RMS co-localized strongly with DLX2 immunoreactivity (<xref ref-type="fig" rid="fig1">Figure 1H</xref>, close up H’, H’).</p><p>Altogether, the combination of microarray studies in defined neuronal lineages and histological approaches led to the conclusion that <italic>Vax1</italic> is expressed in the lateral and ventral SVZ in a subset of proliferating precursors and in most neuroblasts, the latter maintaining expression during their migration in the RMS.</p></sec><sec id="s2-2"><title><italic>Vax1</italic> is necessary for the generation of calbindin-positive interneurons</title><p>Previous work demonstrated that CB-N destined for the GL are generated from the ventral-most region of the anterior lateral ventricles (LV), and SHH signaling has been implicated in their specification (<xref ref-type="bibr" rid="bib31">Merkle et al., 2007</xref>; <xref ref-type="bibr" rid="bib23">Ihrie et al., 2011</xref>). As <italic>Vax1</italic> is strongly expressed in this area, and has been shown to act as an intracellular mediator of SHH signaling (<xref ref-type="bibr" rid="bib41">Take-uchi et al., 2003</xref>; <xref ref-type="bibr" rid="bib17">Furimsky and Wallace, 2006</xref>; <xref ref-type="bibr" rid="bib48">Zhao et al., 2010</xref>), we first asked if the TF is implicated in the generation of the CB-N subtype.</p><p><italic>Vax1</italic> conditionally mutant mice (Vax1cKO) (<xref ref-type="bibr" rid="bib22">Hoffmann et al., 2016</xref>) were bred to R26tdTomato mice to monitor CRE-induced recombination and to follow the distribution and fate of mutant and control cells over time. We used postnatal in vivo brain electroporation to express CRE protein in the lateral wall (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Since targeting of the <italic>Vax1</italic>-positive ventral region of the ventricular wall with DNA-based expression constructs is inefficient, we used <italic>Cre</italic> mRNA, that is highly efficient for the transfection of stem cells along the entire wall, including the most ventral aspect (<xref ref-type="bibr" rid="bib8">Bugeon et al., 2017</xref>). Animals were electroporated at P0 and analyzed 15 days later, when labeled neurons reached the OB and integrated into the GCL and GL (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Quantification of labeled neurons in the GCL and GL revealed no significant differences between control and mutant mice (<xref ref-type="fig" rid="fig2">Figure 2C</xref>; <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). TH-positive PGC were also not significantly affected (Figure 4I). However, there was a significant loss in the small population of CB-positive neurons in the GL (<xref ref-type="fig" rid="fig2">Figure 2D,E</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title><italic>Vax1</italic> is necessary for the production of Calbindin-positive interneurons in the olfactory bulb.</title><p>(<bold>A</bold>) Representation of the <italic>Vax1</italic> conditional allele (Vax1cKO) and the the inducible reporter <italic>tdTomato</italic> allele in the <italic>Rosa26</italic> locus (<italic>R26tdTom</italic>). Right panel: strategy used to recombine the <italic>Vax1</italic> mutant allele in the V-SVZ cells in the lateral wall at postnatal day 0 (P0). TdTomato (Tom)-positive cells were analyzed 15 days post-electroporation (dpe) in the olfactory bulb (OB). (<bold>B</bold>) Images showing the distribution of Tom+ cells (in red) in the OB at 15dpe in control and mutant brains. Nuclei (in blue) are stained by Hoechst. (<bold>C</bold>) Quantification of granule cells (GC) number in the OB GCL in both conditions. Data are shown as means ± SD, dots represent individual animals. WT: n = 12, Vax1cKO: n = 17. (<bold>D</bold>) Images showing Calbindin+ (in green) and Tom+ cells in the GL at 15dpe. Arrow heads indicate double stained neurons. High magnification of representative double positive cells is shown below. (<bold>E</bold>) Quantification of the percentage of Calbindin+ neurons among the Tom+ PGC population (WT: n = 11, Vax1cKO: n = 17) showing reduction of CB-N in the mutant. GCL: granule cell layer, GL: glomerular layer. *p≤0.05. Scale bars: 200 µm (<bold>B</bold>), 50 µm (<bold>D</bold>).</p><p> <supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Quantification of tdTomato+ granule cells and Calbindin+ PGC in <italic>Vax1</italic> mutant.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-58215-fig2-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58215-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>CRE-recombination of the <italic>Vax1<sup>flox</sup></italic> allele in progenitors induce a substantial reduction of <italic>Vax1</italic> mRNA expression in the homozygote mutant (Vax1cKO) compared to WT animal.</title><p>(<bold>A</bold>) Strategy used to target lateral V-SVZ NSCs with <italic>Cre</italic>-mRNA. Tomato+ recombined cells were isolated 2 days after electroporation. (<bold>B</bold>) <italic>Vax1</italic> mRNA level quantified by RT-PCR was normalized to beta-actin and reported in Vax1cKO condition as relative level to control (WT).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58215-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Quantification of tdTomato-positive periglomerular cell (PGC) number in the OB of <italic>Vax1</italic> mutant brains.</title><p>Cells were analyzed 15 days after electroporation of lateral V-SVZ progenitors by <italic>Cre</italic> mRNA in WT or Vax1cKO mice. Data are shown as means ± SD, dots represent individual animals. WT: n = 12, Vax1cKO: n = 17.</p><p> <supplementary-material id="fig2s2sdata1"><label>Figure 2—figure supplement 2—source data 1.</label><caption><title>Quantification of tdTomato+ PGC in <italic>Vax1</italic> mutant.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-58215-fig2-figsupp2-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58215-fig2-figsupp2-v2.tif"/></fig></fig-group><p>Thus, <italic>Vax1</italic> expression in the ventro-lateral-derived neurogenic lineage is necessary for the correct generation of CB-N in the GL.</p></sec><sec id="s2-3"><title><italic>Vax1</italic> regulates <italic>Pax6</italic> during OB neurogenesis</title><p>In situ hybridization indicated that <italic>Vax1</italic> mRNA was expressed in a ventro-dorsal gradient (<xref ref-type="fig" rid="fig1">Figure 1</xref>). To confirm the existence of such a gradient, we micro-dissected V-SVZ tissue from the dorsal, dorso-lateral, and ventro-lateral regions of the ventricular walls of postnatal and adult mice and subjected the isolates to RT-qPCR analyses for <italic>Vax1</italic> mRNA. In agreement with the histological data, <italic>Vax1</italic> mRNA showed a steep ventro-dorsal gradient, opposed to, and partially overlapping with, the well-described localization of <italic>Pax6</italic> mRNA, that extends dorso-ventrally (<xref ref-type="fig" rid="fig3">Figure 3A</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>; <xref ref-type="bibr" rid="bib11">de Chevigny et al., 2012a</xref>). This observation appeared significant for two main reasons. First, several studies provided evidence that <italic>Vax1</italic> can negatively regulate <italic>Pax6</italic> expression during development (<xref ref-type="bibr" rid="bib6">Bertuzzi et al., 1999</xref>; <xref ref-type="bibr" rid="bib21">Hallonet et al., 1999</xref>; <xref ref-type="bibr" rid="bib33">Mui et al., 2005</xref>). Second, repression of <italic>Pax6</italic> translation along the lateral wall is necessary to confine Pax6 protein, and consequently DA-N phenotype, to the dorsal stem cell pool (<xref ref-type="bibr" rid="bib11">de Chevigny et al., 2012a</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title><italic>Vax1</italic> inhibits PAX6 expression in the V-SVZ and the OB.</title><p>(<bold>A</bold>) Quantitative RT-PCR revealing <italic>Vax1</italic> and <italic>Pax6</italic> gene expression in tissue micro-dissected from three distinct areas of the V-SVZ. D: dorsal, DL: dorso-lateral, VL: ventro-lateral. (<bold>B</bold>) Strategy design for the <italic>Vax1</italic> gain-of-function experiment. The <italic>Vax1</italic> expressing plasmid (pCAG-Vax1) was introduced into lateral or dorsal progenitors in combination with pCX-GFP by electroporation at P1. Brains were analyzed at different time points in the V-SVZ or the OB. (<bold>C</bold>) Representative images showing simultaneous expression of PAX6 and GFP proteins in dorsal or lateral lineage in the V-SVZ. (<bold>D</bold>) High-magnification images illustrating the downregulation of Pax6 in GFP+ cells after electroporation of lateral V-SVZ by <italic>Vax1</italic>. White arrows: GFP/Pax6 double positive cells, yellow arrows point to cells with reduced or absentPax6 expression. (<bold>E</bold>) Quantification of PAX6 mean intensity in control or <italic>Vax1</italic>-overexpressing (OE) V-SVZ GFP+ cells from dorsal (D, n = 6 for the control, n = 7 for Vax1 condition) or lateral (L, n = 6 for the CTL, n = 7 for Vax1 condition) walls. (<bold>F</bold>) Images showing simultaneous expression of PAX6 and GFP in the OB glomerular layer of control or Vax1OE brains. Arrow head: double GFP/PAX6-positive cells; yellow arrow: GFP only cells. (<bold>G</bold>) Quantification of GFP+PAX6+ neurons in the OB GL at 15dpe (n = 6 for the CTL, n = 6 for Vax1OE) and 25dpe (n = 8 for the CTL, n = 6 for Vax1OE). PGC: periglomerular cell. *p≤0.05, **p≤0.01. Scale bars: 50 µm (<bold>C,F</bold>), 10 µm (<bold>D</bold>).</p><p> <supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Quantification of PAX6 in <italic>Vax1</italic>-overexpressing progenitors and neurons.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-58215-fig3-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58215-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Quantitative RT-PCR revealing <italic>Vax1</italic> gene expression in adult brain.</title><p>Cells were dissected out from three distinct areas of the V-SVZ. Error bars represent technical triplicate. D: dorsal, DL: dorso-lateral, VL: ventro-lateral.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58215-fig3-figsupp1-v2.tif"/></fig></fig-group><p>Based on this information, we hypothesized that <italic>Vax1</italic> is implicated in <italic>Pax6</italic> down-regulation in the postnatal SVZ. To test this, we overexpressed Vax1 in the dorsal and lateral neurogenic lineages by electroporation and investigated the impact on Pax6 expression. A <italic>Vax1</italic> expression plasmid (pCAG-Vax1), or an empty control vector, was co-electroporated with pCX-GFP into either the dorsal or the lateral ventricular wall (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Two days later, animals were sacrificed and intensity of Pax6 immunostaining in GFP-positive cells was measured in the dorsal and dorso-lateral SVZ (<xref ref-type="fig" rid="fig3">Figure 3C,D,E</xref>). GFP-positive cells generated in both compartments showed a significant decrease in Pax6 expression levels at this early time point (<xref ref-type="fig" rid="fig3">Figure 3D,E</xref>).</p><p>Then we asked if Pax6 expression was affected at late time points, after the arrival of newborn neurons in the OB GL. Indeed, 15 and 25 days after pCAG-Vax1 electroporation into the dorsal wall the proportion of GFP-positive neurons that showed Pax6 expression was reduced by over 80% (<xref ref-type="fig" rid="fig3">Figure 3F,G</xref>).</p><p>We conclude that <italic>Vax1</italic> has the capacity to act as a negative regulator of <italic>Pax6</italic> expression during postnatal OB neurogenesis.</p></sec><sec id="s2-4"><title><italic>Vax1</italic> negatively regulates dopaminergic phenotype</title><p>DA-N in the OB GL are derived from the dorsal and dorso-lateral aspects of the ventricle walls (<xref ref-type="bibr" rid="bib31">Merkle et al., 2007</xref>; <xref ref-type="bibr" rid="bib14">Fernández et al., 2011</xref>; <xref ref-type="bibr" rid="bib11">de Chevigny et al., 2012a</xref>) and <italic>Pax6</italic> expression is necessary and sufficient for the acquisition of this neurotransmitter phenotype (<xref ref-type="bibr" rid="bib19">Hack et al., 2005</xref>; <xref ref-type="bibr" rid="bib25">Kohwi et al., 2005</xref>). We asked if <italic>Vax1</italic> overexpression in Pax6-positive cells was sufficient to inhibit the generation of DA-N in the OB.</p><p>We first targeted the dorsal compartment (<xref ref-type="fig" rid="fig4">Figure 4A–D</xref>), where the majority of DA-N are generated (<xref ref-type="bibr" rid="bib14">Fernández et al., 2011</xref>; <xref ref-type="bibr" rid="bib11">de Chevigny et al., 2012a</xref>). Ectopic expression of <italic>Vax1</italic> led to a significant loss of TH/GFP-positive neurons 15 days later in the OB (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Loss of TH-positive cells was robust over time and could be observed at 25 and 60 dpe (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). Two observations pointed toward the specific loss of dopaminergic neurons. First, the number of the second major identified neuron type that is generated in the dorsal ventricular wall, CR-N of the glomerular layer (<xref ref-type="bibr" rid="bib14">Fernández et al., 2011</xref>; <xref ref-type="bibr" rid="bib43">Tiveron et al., 2017</xref>), was unaffected by <italic>Vax1</italic> expression (<xref ref-type="fig" rid="fig4">Figure 4B</xref>), arguing against a fate shift toward this neuron type (<xref ref-type="bibr" rid="bib43">Tiveron et al., 2017</xref>). Second, the density of total GFP+ cells in the GL of <italic>Vax1</italic>-electroporated animals was significantly reduced (<xref ref-type="fig" rid="fig4">Figure 4D</xref>), whereas the number of GFP+ granule cells was not affected (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). As dopaminergic neurons represent a substantial population of all dorsal generated periglomerular cells such an overall loss is coherent with a loss of the DA-N subtype.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Overexpression of <italic>Vax1</italic> in V-SVZ neural stem cells inhibits dopaminergic phenotype.</title><p>(<bold>A</bold>) Experimental design (left) for the electroporation of NSCs in the dorsal wall with pGAC-Vax1 + pCX-GFP. Images (right) showing expression of Tyrosine Hydroxylase (TH) and Calretinin (CR) in the OB glomerular layer 15 days after electroporation in <italic>Vax1</italic> over-expression (OE) and control brains. White arrow head: GFP/CR- double positive neuron, yellow arrow head: GFP/TH double positive neuron, yellow arrow: GFP-only cell. (<bold>B</bold>) Histogram showing the reduction of the density of GFP+ periglomerular cells (PGC) in the Vax1OE OB (CTL n = 15, Vax1 n = 14). (<bold>C</bold>) The quantification of TH+ and CR+/GFP-positive cells shows a large decrease of the proportion of dopaminergic neurons among the total GFP+ cells in the OB of Vax1 condition (TH n = 14, CR n = 15) compared to control (n = 13/14). (<bold>D</bold>) The reduction of the TH+ population is sustained with time as it is still observed at 25- (CTL n = 7, Vax1 n = 5) and 60- (CTL n = 5, Vax1 n = 4) days post electroporation. (<bold>E</bold>) Experimental design (left) for the electroporation of NSCs in the lateral wall with pGAC-Vax1 + pCX-GFP. Representative images (right) of immunostaining with TH, Calbindin (CB), and CR antibodies in the OB GL. Arrow head: example of double positive staining with GFP for each marker. (<bold>F</bold>) Histogram presenting the quantification of the three different neuronal populations among the GFP+ neurons in the OB of control (n = 10 for each marker) or Vax1OE (TH n = 11, CB and CR n = 9) conditions. (<bold>G</bold>) Histogram showing the density of GFP + PGC in both conditions (CTL n = 10, Vax1 n = 10). (<bold>H</bold>) Lateral NSCs of Vax1cKO: rosa26tdTom brains were electroporated at birth with pCX-CRE and neuronal phenotype was analyzed in OB at 15 dpe. Representative images of TH staining in the GL of control or <italic>Vax1</italic> deficient OB. Arrow head: GFP+ cells co-labelled with TH. Insert: high magnification of a double positive neuron. (<bold>I</bold>) Histograms presenting the percentage of TH+ neurons among Tom+ PGC (CTL: n = 12, three independent litters; Vax1: n = 12, three independent litters). A slight increase of the TH+ population was observed in absence of <italic>Vax1</italic> compared to control but statistical test (Mann Whitney U test) failed to give significant p values (p=0.16). **p≤0.01, ****p≤0.0001. All scale bars: 20 µm except in H (50 µm).</p><p> <supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Quantification of OB neuronal subpopulations in <italic>Vax1</italic>- overexpressing or <italic>Vax1</italic> mutant mice.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-58215-fig4-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58215-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Forced expression of <italic>Vax1</italic> has no effect on cell density in the OB granule cell (GC) layer, 15 days after electroporation of dorsal (CTL n = 15, Vax1 n = 14) or (<bold>B</bold>) lateral (n = 10 for both conditions) V-SVZ progenitors.</title><p>Data are represented by mean ± SEM.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58215-fig4-figsupp1-v2.tif"/></fig></fig-group><p>Next, we targeted the lateral ventricular wall (<xref ref-type="fig" rid="fig4">Figure 4E–G</xref>), where smaller but still significant numbers of DA-N are produced from a dorso-lateral stem cell pool (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). Overexpression of <italic>Vax1</italic> in the lateral wall induced a significant loss of TH-positive neurons in the GL 15 days later (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). At the same time point, numbers of CB-N and CR-N were unchanged (<xref ref-type="fig" rid="fig4">Figure 4F</xref>), indicating again that no phenotypic switch toward these subtypes occurred. The density of GFP+ cells was also unaffected in both GL (<xref ref-type="fig" rid="fig4">Figure 4G</xref>) and GCL (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). Thus, <italic>Vax1</italic> overexpression specifically inhibits DA-N phenotype of newborn neurons in the OB.</p><p>We also investigated whether <italic>Vax1</italic> loss-of-function had a positive impact on DA-N phenotype in the OB. NSCs along the lateral wall of Vax1cKO animals were electroporated with pCX-CRE (<xref ref-type="fig" rid="fig4">Figure 4H</xref>) and the proportion of TH-positive neurons in the OB was analyzed 15 days later. These analyses failed to show a significant increase in DA-N at a confidence level of p≤0.05 (<xref ref-type="fig" rid="fig4">Figure 4I</xref>).</p><p>We conclude that <italic>Vax1</italic>, likely via regulation of <italic>Pax6</italic>, has the capacity to negatively control the generation of DA-N for the OB. Moreover, these data show that while <italic>Vax1</italic> is necessary for the generation of CB-N, it is not sufficient.</p></sec><sec id="s2-5"><title><italic>Vax1</italic> induces miR-7 expression in the lateral wall</title><p>Previous work demonstrated that mature microRNA miR-7 is expressed in a ventro-dorsal gradient along the lateral ventricular wall and post-transcriptionally inhibits Pax6 protein expression. This interaction confines the generation of DA-N to the very dorso-lateral aspect (<xref ref-type="bibr" rid="bib11">de Chevigny et al., 2012a</xref>). As <italic>Vax1</italic> and miR-7 are expressed in a similar gradient, we hypothesized that the repression of Pax6 protein expression by <italic>Vax1</italic> is mediated by miR-7. To address this idea, we overexpressed Vax1 together with GFP in the lateral stem cell compartment and isolated GFP-positive cells 2 days later by microdissection, dissociation and flow cytometry cell sorting (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). qRT-PCR analyses demonstrated that augmented <italic>Vax1</italic> expression (<xref ref-type="fig" rid="fig5">Figure 5B</xref>) led to a strong increase in miR-7 levels (<xref ref-type="fig" rid="fig5">Figure 5C</xref>), suggesting that <italic>Vax1</italic> regulates <italic>MiR-7</italic> expression. In agreement, bioinformatical analyses of the proximal promoters of the three <italic>MiR-7</italic> loci (<italic>MiR-7–1, MiR-7–2, MiR-7b</italic>) identified a significant match of the Vax1 DNA binding motif within 500 bp of the transcription start site of each of the three <italic>MiR-7</italic> loci present in the mouse genome (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). Altogether, these results suggest that the negative impact of <italic>Vax1</italic> on Pax6 expression is, at least in part, mediated via the positive regulation of <italic>MiR-7</italic>.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title><italic>Vax1</italic> induces the expression of miR-7 in the lateral V-SVZ.</title><p>(<bold>A</bold>) Strategy used to determine the expression of microRNAs in Vax1-overexpressing progenitors. PCAG-Vax1 and pCX-GFP were simultaneously introduced into NSCs by electroporation of the lateral wall of postnatal P1 brains. Lateral V-SVZ was dissected out 2 days after electroporation and GFP+ cells were isolated by flow cytometry (FACS) to perform quantitative RT-PCR analysis. (<bold>B</bold>) Quantification of <italic>Vax1</italic> mRNA level by qRT-PCR in control and Vax1OE conditions, normalized to beta-actin and reported in Vax1 condition as relative level to control, validating the overexpression of <italic>Vax1</italic> after electroporation. (<bold>C</bold>) Quantification of miR-7 expression in both conditions. Expression level of miR-7 was normalized by invariant expression of microRNA let-7a and reported in Vax1 condition as relative level to control. Experiments in B and C were performed in triplicate, and data were obtained from (<bold>B</bold>) two independent biological replications or (<bold>C</bold>) three technical replications. (<bold>D</bold>) Genome browser images representing the chromosomal portions encoding the three <italic>MiR-7</italic> loci (depicted in pink). <italic>Mir-7–1</italic> lies within an intronic sequence of the Hnrnpk gene whereas <italic>MiR-7–2</italic> and <italic>MiR-7b</italic> reside within intergenic sequences. Vax1-binding sites found in the upstream regulatory region of the three <italic>MiR-7</italic> are represented by red boxes. (<bold>E</bold>) Model of cross-regulatory interaction between <italic>Vax1</italic>, miR-7, and <italic>Pax6</italic> in the lateral V-SVZ to control the number of dopaminergic neurons generated by the neural stem cells regionalized in this aspect. This model is supported by our present data and previous work (<xref ref-type="bibr" rid="bib11">de Chevigny et al., 2012a</xref>) where it was shown that miR-7 was required to inhibit PAX6 expression in lateral NSCs to produce the correct number of dopaminergic neurons in the postnatal OB. Here, we propose that <italic>Vax1</italic> acts upstream of miR-7 by positively regulating its expression and consequently inhibiting PAX6. However, it is also possible that <italic>Vax1</italic> directly represses the expression of <italic>Pax6</italic> mRNA (dashed line) by acting on its promoter (<xref ref-type="bibr" rid="bib33">Mui et al., 2005</xref>). Additionally, <italic>Vax1</italic> is required to generate Calbindin neurons from the ventral aspect of the lateral V-SVZ.</p><p> <supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Quantification of expression level of <italic>Vax1</italic> and miR-7 in V-SVZ cells.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-58215-fig5-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58215-fig5-v2.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Here, we show that <italic>Vax1</italic> is strongly expressed in the ventral stem cell compartment of the OB neurogenic system where it is necessary for the generation of CB-N. In addition to this actively phenotype-determining function, our data show that <italic>Vax1</italic> acts as a negative regulator of Pax6, likely via the induction of miR-7, thereby restricting the generation of DA-N, which are generated in a neighboring progenitor domain (<xref ref-type="fig" rid="fig5">Figure 5E</xref>; <xref ref-type="bibr" rid="bib11">de Chevigny et al., 2012a</xref>).</p><p>During nervous system development, determination of neuronal phenotype is controlled by the combinatorial expression of transcription factors (<xref ref-type="bibr" rid="bib16">Flames et al., 2007</xref>; <xref ref-type="bibr" rid="bib18">Guillemot, 2007</xref>; <xref ref-type="bibr" rid="bib26">Lai et al., 2016</xref>). Moreover, cross regulatory interactions between such TFs have been shown to tightly define progenitor domains that generate specific neuron subtypes (<xref ref-type="bibr" rid="bib24">Jessell, 2000</xref>; <xref ref-type="bibr" rid="bib36">Sagner and Briscoe, 2019</xref>). Such spatial information has to be maintained during postnatal and adult stages and neuronal output has to be adapted to the needs of the ongoing neurogenesis in the OB. In agreement, regionalization of the postnatal stem cell compartment has been shown to depend on spatially restricted and combinatorial expression of TFs like, for example, Pax6, Emx1, Gsx1/2, Gli1/2, or Zic1/2 (<xref ref-type="bibr" rid="bib1">Alvarez-Buylla et al., 2008</xref>; <xref ref-type="bibr" rid="bib45">Weinandy et al., 2011</xref>; <xref ref-type="bibr" rid="bib15">Fiorelli et al., 2015</xref>; <xref ref-type="bibr" rid="bib3">Angelova et al., 2018</xref>).</p><p>CB-N are produced by NSCs positioned in the ventral aspect of the V-SVZ (<xref ref-type="bibr" rid="bib31">Merkle et al., 2007</xref>) and SHH signaling, via its effector GLI1, has been implicated in the specification of this subtype (<xref ref-type="bibr" rid="bib23">Ihrie et al., 2011</xref>). Interestingly, previous work demonstrated that Vax1 expression is positively controlled by SHH signaling (<xref ref-type="bibr" rid="bib21">Hallonet et al., 1999</xref>; <xref ref-type="bibr" rid="bib41">Take-uchi et al., 2003</xref>; <xref ref-type="bibr" rid="bib17">Furimsky and Wallace, 2006</xref>). In light of our finding that <italic>Vax1</italic> deletion also leads to specific loss of CB-N, it appears probable that <italic>Vax1</italic> acts downstream of SHH expression in the ventral SVZ to control CB-N production for the OB.</p><p>In addition to this local role in CB-N generation, <italic>Vax1</italic> regulates the generation of a neighboring neuron type. Indeed, its expression extends in a gradient far into dorsal regions of the ventricular wall, where Pax6 is expressed and acts as a key component of DA-N generation (<xref ref-type="bibr" rid="bib11">de Chevigny et al., 2012a</xref>). Forced expression of <italic>Vax1</italic> in the <italic>Pax6</italic>-positive domains was sufficient to reduce PAX6 protein expression and to inhibit the production of DA-N, but not of other neuron types, in the OB. This strongly indicates that <italic>Vax1</italic> acts as a repressor of Pax6, comparable to the situation in the developing eye (<xref ref-type="bibr" rid="bib6">Bertuzzi et al., 1999</xref>; <xref ref-type="bibr" rid="bib21">Hallonet et al., 1999</xref>; <xref ref-type="bibr" rid="bib33">Mui et al., 2005</xref>).</p><p>Loss-of-function of <italic>Vax1</italic> through targeted electroporation with a CRE expression vector in the lateral wall of conditional mutants did not lead to a statistically significant increase in DA-N at the classically used confidence level of p≤0.05. The observed tendency toward DA-N increase was, however, quite robust over several independent electroporation approaches implicating a large cohort of animals. We decided to include these data, as they complement the gain-of-function approach and as we believe that they could be biologically relevant. Indeed, the cell population in the lateral wall that will be able to induce DA-N fate after deletion of <italic>Vax1</italic> is probably quite small. A large proportion of cells targeted by electroporation in the dorso-lateral wall do not express <italic>Vax1</italic> and these cells will follow their normal differentiation program after recombination. Only cells in intermediate positions, that express sufficiently high Pax6 levels to be able to induce the DA-N phenotype, while at the same time having sufficient <italic>Vax1</italic> levels to suppress this differentiation pathway, will show a DA-N phenotype after <italic>Vax1</italic> removal. In addition, other factors, like lower recombination efficiency of the <italic>Vax1</italic> allele versus the <italic>R26tdTomato</italic> allele, might further diminish the number of cells in which the impact of gene inactivation can be studied (<xref ref-type="bibr" rid="bib28">Long and Rossi, 2009</xref>; <xref ref-type="bibr" rid="bib30">Luo et al., 2020</xref>). Thus, while our electroporation approach allows targeting and manipulating specific stem cell compartments, it also has limitations that restrict interpretation.</p><p>Finally, the implication of microRNAs introduces an additional level of complexity into the cross regulatory machinery that underlies OB interneuron fate determination. In previous work, we demonstrated that PAX6 protein, and consequently DA-N production, is confined to the dorsal aspect of the lateral ventricle wall by post-transcriptional regulation of the <italic>Pax6</italic> 3’UTR by the microRNA mir-7. The latter is, like <italic>Vax1</italic>, expressed in a ventro-dorsal and <italic>Pax6</italic> opposing gradient. Thus, it is tempting to speculate that the repression of Pax6 by <italic>Vax1</italic> is, at least in part, indirect and produced via activation of miR-7. Our finding that overexpression of <italic>Vax1</italic> in vivo induced a strong increase in miR-7 levels, and the presence of Vax1-binding sites in all three <italic>MiR-7</italic> promoter regions supports such a scenario. Indeed, regulatory networks implicating transcription factors and miRNAs have been described in other contexts of developmental neurogenesis. For example, in the developing spinal cord, progenitor domains producing defined types of interneurons depend on the cross regulation between the transcription factors Olig2 and Irx3. This interaction is fine-tuned by the induction of miR-17–3 p that represses Olig2 and refines the boundary between domains (<xref ref-type="bibr" rid="bib10">Chen et al., 2011</xref>). Thus, such regulatory modules could be a general mechanism to assure the precise definition of progenitor compartments.</p><p>In conclusion, we identified in the postnatal brain a regulatory network, based on transcription factors and miRNAs, which controls the regionalization of the stem cell compartment (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). The observation that the ventro-dorsally oriented <italic>Vax1</italic> gradient (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>) as well as the graded expression of <italic>Pax6</italic> and miR-7 (<xref ref-type="bibr" rid="bib11">de Chevigny et al., 2012a</xref>) are maintained in adult stages points to the possibility that this regulatory cascade is also active in adult neurogenesis.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th valign="top">Reagent type <break/>(species) or resource</th><th valign="top">Designation</th><th valign="top">Source or reference</th><th valign="top">Identifiers</th><th valign="top">Additional <break/>information</th></tr></thead><tbody><tr><td valign="top">Strain, strain background (<italic>Mus musculus</italic>)</td><td valign="top"><italic>Vax1<sup>flox</sup></italic></td><td valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/27013679">27013679</ext-link></td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/MGI:5796178">MGI:5796178</ext-link></td><td valign="top"/></tr><tr><td valign="top">Strain, strain background (<italic>Mus musculus</italic>)</td><td valign="top"><italic>Gt(ROSA)26Sor<sup>tm14(CAG-tdTomato)Hze</sup></italic> (Ai14)</td><td valign="top">Jackson Laboratories</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX:007914">IMSR_JAX:007914</ext-link></td><td valign="top"/></tr><tr><td valign="top">Strain, strain background (<italic>Mus musculus</italic>)</td><td valign="top">CD1</td><td valign="top">Charles River</td><td valign="top">Crl : CD1(ICR) <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_CRL:022">IMSR_CRL:022</ext-link></td><td valign="top"/></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>Vax1</italic> cDNA</td><td valign="top">GenBank</td><td valign="top">BC111818</td><td valign="top"/></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>Cre</italic> mRNA</td><td valign="top">Miltenyi Biotec</td><td valign="top">130-101-113</td><td valign="top"/></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pCX-EGFP <break/>(plasmid)</td><td valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/17934458">17934458</ext-link></td><td valign="top"/><td valign="top">Dr Xavier Morin (CNRS, Aix-Marseille University)</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pCX-CRE <break/>(plasmid)</td><td valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/17934458">17934458</ext-link></td><td valign="top"/><td valign="top">Dr Xavier Morin (CNRS, Aix-Marseille University)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-digoxigenin (Sheep polyclonal)</td><td valign="top">Roche</td><td valign="top">11093274910 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_514497">AB_514497</ext-link></td><td valign="top">IHC (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-Pax6 <break/>(Rabbit polyclonal)</td><td valign="top">Millipore</td><td valign="top">AB2237 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1587367">AB_1587367</ext-link></td><td valign="top">IF, IHC (1: 1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-Ascl1 <break/>(mouse monoclonal)</td><td valign="top">BD Biosciences</td><td valign="top">556604 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_396479">AB_396479</ext-link></td><td valign="top">IHC (1:100)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-Ki67 <break/>(mouse monoclonal)</td><td valign="top">BD Biosciences</td><td valign="top">550609 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_393778">AB_393778</ext-link></td><td valign="top">IHC (1:200)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-Dlx2 <break/>(guinea pig polyclonal)</td><td valign="top">Prof. K. Yoshikawa, Osaka University, Osaka, Japan</td><td valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/16707790">16707790</ext-link></td><td valign="top">IHC (1: 2000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-Calbindin D-28K <break/>(Rabbit polyclonal)</td><td valign="top">Millipore</td><td valign="top">AB1778 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2068336">AB_2068336</ext-link></td><td valign="top">IF (1 :1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-Calbindin D-28K <break/>(mouse monoclonal)</td><td valign="top">Swant</td><td valign="top">300 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10000347">AB_10000347</ext-link></td><td valign="top">IF (1:3000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti- Calretinin <break/>(mouse monoclonal)</td><td valign="top">Synaptic systems</td><td valign="top">214111 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2619906">AB_2619906</ext-link></td><td valign="top">IF (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-Tyrosine hydroxylase (chicken polyclonal)</td><td valign="top">Avès Labs</td><td valign="top">TYH, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10013440">AB_10013440</ext-link></td><td valign="top">IF (1:1000)</td></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">SYBR GreenER qPCR SuperMix</td><td valign="top">ThermoFisher Scientific</td><td valign="top">11762100</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">miScript SYBR Green PCR Kit</td><td valign="top">Qiagen</td><td valign="top">218073</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">miRCURY LNA miRNA PCR Assay</td><td valign="top">Qiagen</td><td valign="top">339306</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">miRNAeasy kit</td><td valign="top">Qiagen</td><td valign="top">217004</td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">ZEN Blue</td><td valign="top">Zeiss</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_013672">SCR_013672</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Axiovision imaging system</td><td valign="top">Zeiss</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_002677">SCR_002677</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Fiji</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="http://fiji.sc">http://fiji.sc</ext-link></td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_002285">SCR_002285</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">ImageJ</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://imagej.nih.gov/ij/">https://imagej.nih.gov/ij/</ext-link></td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_003070">SCR_003070</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">R Commander</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=Rcmdr">https://CRAN.R-project.org/package=Rcmdr</ext-link></td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_001905">SCR_001905</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">FlowJo</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://www.flowjo.com/solutions/flowjo">https://www.flowjo.com/solutions/flowjo</ext-link></td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_008520">SCR_008520</ext-link></td><td valign="top"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Animals</title><p>All animal procedures were carried out in accordance to the European Communities Council Directie 2010/63/EU and approved by French ethical committees (Comité d'Ethique pour l'expérimentation animale no. 14; permission numbers: 00967.03; 2017112111116881 v2). Animals were held on a 12 h day/night cycle and had access to food and water ad libitum. Animals of both sexes were used for experiments. CD1 mice (Charles River, Lyon, France) were used for in vivo electroporation and expression pattern analyses. <italic>Vax1<sup>flox</sup></italic> (Vax1cKO) conditional mutants (Hoffman 2016) and <italic>Rosa26<sup>tdTomato</sup></italic> reporter mice (Ai14, Jackson Laboratories, USA, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX:007914">IMSR_JAX:007914</ext-link>) were bred on a mixed C57BL/6*CD1 genetic background. <italic>Vax1flox</italic> genotyping was performed with <italic>Vax1flox</italic> forward: 5’-<named-content content-type="sequence">GCCGGAACCGAAGTTCCTA</named-content>; <italic>Vax1wt</italic> forward: 5’-<named-content content-type="sequence">CCAGTAAGAGCCCCTTTGGG</named-content>, reverse 5’-<named-content content-type="sequence">CGGATAGACCCCTTGGCATC</named-content>. Ai14 genotyping was performed with <italic>R26wt</italic> forward: 5’-<named-content content-type="sequence">AAGGGAGCTGCAGTGGAGTA</named-content>, reverse 5’-<named-content content-type="sequence">CCGAAAATCTGTGGGAAGTC</named-content>; <italic>R26tdTom</italic> forward: 5’- <named-content content-type="sequence">CTGTTCCTGTACGGCATGG</named-content> and reverse: 5’- <named-content content-type="sequence">GGCATTAAAGCAGCGTATCC</named-content>.</p></sec><sec id="s4-2"><title>Plasmid and in vivo electroporation</title><p>The full-length rat cDNA sequence of <italic>Vax1</italic> was excised from pCMV2-Rn-Vax1-FLAG (a gift of Kapil Bharti) and subcloned into pCAGGS vector to produce pCAG-Vax1. Postnatal day 0 (P0) or day 1 (P1) pups were electroporated as previously described (<xref ref-type="bibr" rid="bib7">Boutin et al., 2008</xref>; <xref ref-type="bibr" rid="bib11">de Chevigny et al., 2012a</xref>) with plasmid DNA or RNA (<xref ref-type="bibr" rid="bib8">Bugeon et al., 2017</xref>). CRE Recombinase mRNA (130-101-113, a generous gift from S. Wild and A. Bosio, Miltenyi Biotec, Bergisch Gladbach, Germany) and pCX-CRE (<xref ref-type="bibr" rid="bib32">Morin et al., 2007</xref>) were used at a concentration of 0.5 µg/µl. Recombination efficiency was tested by qRT-PCR from tdTomato+ cells isolated by FACS (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). In CD1 pups, pCX-EGFP (<xref ref-type="bibr" rid="bib32">Morin et al., 2007</xref>) was co-injected with pCAG-Vax1 or empty pCAGGS (as control) in a 1:2 molecular ratio to label the electroporated cells. Targeting of the dorsal or lateral wall of the lateral ventricle was directed by distinct orientation of the electrodes. Brains were collected at different time points after electroporation.</p></sec><sec id="s4-3"><title>In situ hybridization and immunohistochemistry</title><p>For all procedures, tissues were fixed by intracardiac perfusion with ice-cold 4% paraformaldehyde (wt/vol) in phosphate buffered saline (PBS) and cryoprotected in 30% sucrose solution in PBS. Brains were sliced coronally using either a microtome (Microm Microtech, France) or a cryostat (Leica Biosystems, France).</p><p>Mouse <italic>Vax1</italic> cDNA clone (GeneBank: BC111818, Imagene) was used to produce the anti-sense RNA probe. Combined in situ hybridization (ISH) and immunohistochemistry (IHC) were performed as previously described (<xref ref-type="bibr" rid="bib42">Tiveron et al., 1996</xref>) on 16 µm cryosections at postnatal day 3 (P3) using anti-digoxigenin antibody (Sheep polyclonal, 1:1000, Roche, 11093274910, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_514497">AB_514497</ext-link>). Two days exposure to alkaline phosphatase (AP) substrate NBT/BCIP (Promega, S3771) was necessary to detect AP-DIG-labeled <italic>Vax1</italic> mRNA at maximal level. Subsequently, antibodies directed against PAX6 (rabbit polyclonal, 1: 1000, Millipore, AB2237, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1587367">AB_1587367</ext-link>), KI67 (mouse IgG1k clone B56, 1:200, BD Biosciences, 550609, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_393778">AB_393778</ext-link>), ASCL1 (mouse, clone 24B72D11.1, 1:100, BD Biosciences, 556604, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_396479">AB_396479</ext-link>), or DLX2 (rabbit polyclonal, 1: 2000 a gift from Prof. K. Yoshikawa) were applied to the ISH treated sections and were revealed with secondary antibodies coupled to horseradish peroxidase (Jackson ImmunoResearch Laboratories, UK), using 3, 3’-Diaminobenzidine (Invitrogen, 750118) as a substrate. Sections were finally mounted in fluoromount medium and analyzed by light microscopy using Axiovision Rel. 4.8 software (Zeiss, Germany).</p><p>For immunofluorescence, 50 µm floating sections were blocked in PBS supplemented with 0.5% Triton-X100, 10% foetal calf serum (FCS) and incubated overnight at 4°C in PBS, 0.1% Triton, 5% FCS with primary antibodies: anti-Calbindin D-28K (rabbit polyclonal, 1:1000, Millipore, AB1778, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2068336">AB_2068336</ext-link> or mouse IgG1, 1:3000, Swant, 300, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10000347">AB_10000347</ext-link>), anti-Calretinin (mouse IgG1, clone 37C9, 1:1000, Synaptic systems, 214111, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2619906">AB_2619906</ext-link>), anti-Tyrosine hydroxylase (chicken IgY, 1:1000, Avès labs, TYH, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10013440">AB_10013440</ext-link>). After washing in PBS, Alexa Fluor-conjugated secondary antibodies (Jackson ImmunoResearch Laboratories) were applied diluted at 1:500 in blocking solution for 2 hr at room temperature. After staining of cell nuclei with Hoechst 33258 (Invitrogen, H3569), sections were mounted with Mowiol (Sigma-Aldrich, 81381).</p></sec><sec id="s4-4"><title>RNA isolation, qRT-PCR, cell dissociation, and FACS</title><p>Animals (P1-P3) were decapitated and brains were cut into 300 μm thick sections using a Vibrating-Blade Microtome (Thermo Scientific, HM 650V). V-SVZ and RMS tissues were micro-dissected under a binocular microscope and kept in cold Hank’s balanced salt solution (HBSS, Gibco, 14170120). RNA was extracted using the miRNAeasy kit (Qiagen, 217004) or by Trizol reagent (life technologies, 15596026) according to manufacturer instructions, allowing the recovery of long and short RNAs. For <italic>Pax6</italic> and <italic>Vax1</italic> expression analysis, cDNA was prepared using superscript III reverse transcriptase (ThermoFisher Scientific, 12574–030) following manufacturer instructions and quantitative PCR was performed on a BioRad CFX system using SYBR GreenER qPCR SuperMix (ThermoFisher Scientific, 11762100) in technical triplicates. ß-Actin was used as reference gene. Primers used for mRNA detection are the following: Beta Actin forward 5’-<named-content content-type="sequence">CTAAGGCCAACCGTGAAAAG</named-content> and reverse 5’-<named-content content-type="sequence">ACCAGAG</named-content> <named-content content-type="sequence">GCATACAGGGACA</named-content>; Pax6 forward 5’-<named-content content-type="sequence">TGAAGCGGAAGCTGCAAAGAAA</named-content> and reverse 5’-<named-content content-type="sequence">TTTGGCCCTTCGATTAGAAAACC</named-content>; Vax1 forward 5’- <named-content content-type="sequence">GCTTCGGAAGATTGTAACAAAAG</named-content> and reverse 5’- <named-content content-type="sequence">GGATAGACCCCTTGGCATC</named-content>.</p><p>For miRNA expression, cDNA was prepared using miScript II (Qiagen, 218160) and qPCR was performed using miScript SYBR Green PCR Kit (Qiagen, 218073) together with miRCURY LNA miRNA PCR Assay (Qiagen, 339306) on a StepOne Real-Time PCR System (Applied Biosystems). Let-7a was used as normalizer miRNA. Three independent technical replications for each condition were processed in triplicates.</p><p>To generate single-cell suspensions for FACS, dissected tissues were subjected to cell dissociation using a Papain solution and mechanical dissociation as described previously (<xref ref-type="bibr" rid="bib29">Lugert et al., 2010</xref>). Cells were resuspended in HBSS/Mg/Ca supplemented with 10 mM HEPES (Gibco, 15630080), 40 μg/ml DNase I (Roche, 10104159001), 4.5 g/L Glucose (Gibco, A2494001) and 2 mM EDTA, filtered through a 30 μm pre-separation filter (Miltenyi Biotec, 130-041-407) and sorted on MoFlo Astrios EQ cytometer (Beckman- Coulter) gating on GFP- or tdTomato- positive population.</p></sec><sec id="s4-5"><title>Bioinformatics analysis</title><p>Significant Vax1 DNA binding motif (JASPAR Core position-weight matrix MA0722.1) occurrences in the three <italic>MiR-7</italic> loci (<italic>MiR7-1, MiR7-2, MiR7b</italic>) proximal promoters (defined as 500 bp upstream of the transcription start site) from the <italic>Mus musculus</italic> mm10 genome were determined using FIMO from the MEME suite (<xref ref-type="bibr" rid="bib4">Bailey et al., 2009</xref>) with a maximum <italic>p-</italic>value limit of 0.001. FIMO-derived p-values of motif matches in the promoters were 0.000173 (<italic>MiR7-1</italic>), 0.000333 (<italic>MiR7-2</italic>), and 0.000806 (<italic>MiR7b</italic>). Genome browser images were created using the UCSC Genome Browser.</p></sec><sec id="s4-6"><title>Image analyses</title><p>All images were analyzed blind to the experimental condition. Optical images were acquired with an Axioplan2 ApoTome microscope (Zeiss, Germany) using ZEN software (Zeiss, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_013672">SCR_013672</ext-link>), and processing was performed using Fiji software (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_002285">SCR_002285</ext-link>, [<xref ref-type="bibr" rid="bib37">Schindelin et al., 2012</xref>]) or ImageJ (NIH, <ext-link ext-link-type="uri" xlink:href="https://imagej.nih.%20gov/ij/">https://imagej.nih. gov/ij/</ext-link>, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_003070">SCR_003070</ext-link>). ISH/IHC double staining experiments were analyzed by counting labelled SVZ cells along the lateral ventricular wall on 40X magnification images (n = 3 SVZ for Ki67 and Dlx2, n = 8 SVZ for Ascl1). For cell counting in V-SVZ and OB tissues from electroporation experiments, a minimum of three sections per brain (n = animal) were analyzed and the totality of GFP+ or Tomato+ cells of each section were counted. To measure mean intensity of fluorescence after antibody staining, ROI were applied on individual electroporated cells.</p></sec><sec id="s4-7"><title>Statistical analysis</title><p>Control and <italic>Vax1</italic> electroporation assays were performed from the same litter and were reproduced in two or three independent experiments for lateral or dorsal electroporation, respectively. Histograms were drawn with GraphPad Prism version 8 (GraphPad Software, San Diego, CA). Data are presented as mean ± SD. Each sample (n = animal/brain) is represented on histograms by dot. Statistical analyses were performed using R software (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_001905">SCR_001905</ext-link>) and R Commander Package (<ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=Rcmdr">https://CRAN.R-project.org/package=Rcmdr</ext-link>). The non-parametric two-tailed Mann Whitney U test was performed for all in vivo experiments, on pooled experimental repetitions when appropriate. Differences were considered statistically significant when p≤0.05.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title> <p>We thank the members of the Cremer lab for support and critical reading of the manuscript. We are grateful to S Wild and A Bosio from Miltenyi Biotec for providing CRE-mRNA. We thank Kapil Bharti (NIH, Bethesda, USA) for sharing Vax1 cDNA. We thank the local PiCSL-FBI core facility (IBDM, AMU-Marseille) supported by the French National Research Agency through the « Investments for the Future’ program (France-BioImaging, ANR-10-INBS-04) as well as the IBDM animal facility. We are grateful to AMUTICYT Cytometry and Cell Sorting Core facility, AMU, UMR-S 1076. This work was supported by the Agence National pour la Recherche (grants ANR- 13-BSV4-0013 and ANR- 17-CE16-0025), Fondation pour la Recherche Medicale (FRM) ‘Label Equipe FRM’ and Fondation de France (FDF) grant FDF70959 to HC. AE was supported for a postdoctoral fellowship from the Swiss National Funds. NIH grants to PLM in support of this work are P50 HD12303, R01 HD072754, R01 HD082567, P30 CA23100, P30 DK063491, and P42 ES010337. HMH was supported by NIH K99 HD084759.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Validation, Investigation, Visualization, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Investigation</p></fn><fn fn-type="con" id="con3"><p>Resources</p></fn><fn fn-type="con" id="con4"><p>Resources</p></fn><fn fn-type="con" id="con5"><p>Investigation</p></fn><fn fn-type="con" id="con6"><p>Supervision, Funding acquisition, Investigation, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con7"><p>Supervision, Funding acquisition, Writing - original draft, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other" id="fn1"><p>Animal experimentation: All animal procedures were carried out in accordance to the European Communities Council Directie 2010/63/EU and approved by French ethical committees (Comité d'Ethique pour l'expérimentation animale no. 14; permission numbers: 00967.03; 2017112111116881v2).</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-58215-transrepform-v2.pdf"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript.</p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Alvarez-Buylla</surname> <given-names>A</given-names></name><name><surname>Kohwi</surname> <given-names>M</given-names></name><name><surname>Nguyen</surname> <given-names>TM</given-names></name><name><surname>Merkle</surname> <given-names>FT</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The heterogeneity of adult neural stem cells and the emerging complexity of their niche</article-title><conf-name>Cold Spring Harbor Symposia on Quantitative Biology</conf-name><fpage>357</fpage><lpage>365</lpage></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvarez-Buylla</surname> <given-names>A</given-names></name><name><surname>Garcia-Verdugo</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Neurogenesis in adult subventricular zone</article-title><source>The Journal of Neuroscience</source><volume>22</volume><fpage>629</fpage><lpage>634</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.22-03-00629.2002</pub-id><pub-id pub-id-type="pmid">11826091</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angelova</surname> <given-names>A</given-names></name><name><surname>Tiveron</surname> <given-names>MC</given-names></name><name><surname>Cremer</surname> <given-names>H</given-names></name><name><surname>Beclin</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Neuronal subtype generation during postnatal olfactory bulb neurogenesis</article-title><source>Journal of Experimental Neuroscience</source><volume>12</volume><elocation-id>117906951875567</elocation-id><pub-id pub-id-type="doi">10.1177/1179069518755670</pub-id><pub-id pub-id-type="pmid">29511358</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailey</surname> <given-names>TL</given-names></name><name><surname>Boden</surname> <given-names>M</given-names></name><name><surname>Buske</surname> <given-names>FA</given-names></name><name><surname>Frith</surname> <given-names>M</given-names></name><name><surname>Grant</surname> <given-names>CE</given-names></name><name><surname>Clementi</surname> <given-names>L</given-names></name><name><surname>Ren</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>WW</given-names></name><name><surname>Noble</surname> <given-names>WS</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>MEME SUITE: tools for motif discovery and searching</article-title><source>Nucleic Acids Research</source><volume>37</volume><fpage>W202</fpage><lpage>W208</lpage><pub-id pub-id-type="doi">10.1093/nar/gkp335</pub-id><pub-id pub-id-type="pmid">19458158</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bäumer</surname> <given-names>N</given-names></name><name><surname>Marquardt</surname> <given-names>T</given-names></name><name><surname>Stoykova</surname> <given-names>A</given-names></name><name><surname>Ashery-Padan</surname> <given-names>R</given-names></name><name><surname>Chowdhury</surname> <given-names>K</given-names></name><name><surname>Gruss</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Pax6 is required for establishing naso-temporal and dorsal characteristics of the optic vesicle</article-title><source>Development</source><volume>129</volume><fpage>4535</fpage><lpage>4545</lpage><pub-id pub-id-type="pmid">12223410</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertuzzi</surname> <given-names>S</given-names></name><name><surname>Hindges</surname> <given-names>R</given-names></name><name><surname>Mui</surname> <given-names>SH</given-names></name><name><surname>O'Leary</surname> <given-names>DD</given-names></name><name><surname>Lemke</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>The homeodomain protein vax1 is required for axon guidance and major tract formation in the developing forebrain</article-title><source>Genes &amp; Development</source><volume>13</volume><fpage>3092</fpage><lpage>3105</lpage><pub-id pub-id-type="doi">10.1101/gad.13.23.3092</pub-id><pub-id pub-id-type="pmid">10601035</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boutin</surname> <given-names>C</given-names></name><name><surname>Diestel</surname> <given-names>S</given-names></name><name><surname>Desoeuvre</surname> <given-names>A</given-names></name><name><surname>Tiveron</surname> <given-names>MC</given-names></name><name><surname>Cremer</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Efficient in vivo electroporation of the postnatal rodent forebrain</article-title><source>PLOS ONE</source><volume>3</volume><elocation-id>e1883</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0001883</pub-id><pub-id pub-id-type="pmid">18382666</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bugeon</surname> <given-names>S</given-names></name><name><surname>de Chevigny</surname> <given-names>A</given-names></name><name><surname>Boutin</surname> <given-names>C</given-names></name><name><surname>Coré</surname> <given-names>N</given-names></name><name><surname>Wild</surname> <given-names>S</given-names></name><name><surname>Bosio</surname> <given-names>A</given-names></name><name><surname>Cremer</surname> <given-names>H</given-names></name><name><surname>Beclin</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Direct and efficient transfection of mouse neural stem cells and mature neurons by <italic>in vivo</italic> mRNA electroporation</article-title><source>Development</source><volume>144</volume><fpage>3968</fpage><lpage>3977</lpage><pub-id pub-id-type="doi">10.1242/dev.151381</pub-id><pub-id pub-id-type="pmid">28982684</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaker</surname> <given-names>Z</given-names></name><name><surname>Codega</surname> <given-names>P</given-names></name><name><surname>Doetsch</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A mosaic world: puzzles revealed by adult neural stem cell heterogeneity</article-title><source>Wiley Interdisciplinary Reviews: Developmental Biology</source><volume>5</volume><fpage>640</fpage><lpage>658</lpage><pub-id pub-id-type="doi">10.1002/wdev.248</pub-id><pub-id pub-id-type="pmid">27647730</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>J-A</given-names></name><name><surname>Huang</surname> <given-names>Y-P</given-names></name><name><surname>Mazzoni</surname> <given-names>EO</given-names></name><name><surname>Tan</surname> <given-names>GC</given-names></name><name><surname>Zavadil</surname> <given-names>J</given-names></name><name><surname>Wichterle</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Mir-17-3p controls spinal neural progenitor patterning by regulating Olig2/Irx3 Cross-Repressive loop</article-title><source>Neuron</source><volume>69</volume><fpage>721</fpage><lpage>735</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2011.01.014</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Chevigny</surname> <given-names>A</given-names></name><name><surname>Coré</surname> <given-names>N</given-names></name><name><surname>Follert</surname> <given-names>P</given-names></name><name><surname>Gaudin</surname> <given-names>M</given-names></name><name><surname>Barbry</surname> <given-names>P</given-names></name><name><surname>Béclin</surname> <given-names>C</given-names></name><name><surname>Cremer</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2012">2012a</year><article-title>miR-7a regulation of Pax6 controls spatial origin of forebrain dopaminergic neurons</article-title><source>Nature Neuroscience</source><volume>15</volume><fpage>1120</fpage><lpage>1126</lpage><pub-id pub-id-type="doi">10.1038/nn.3142</pub-id><pub-id pub-id-type="pmid">22729175</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Chevigny</surname> <given-names>A</given-names></name><name><surname>Core</surname> <given-names>N</given-names></name><name><surname>Follert</surname> <given-names>P</given-names></name><name><surname>Wild</surname> <given-names>S</given-names></name><name><surname>Bosio</surname> <given-names>A</given-names></name><name><surname>Yoshikawa</surname> <given-names>K</given-names></name><name><surname>Cremer</surname> <given-names>H</given-names></name><name><surname>Beclin</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2012">2012b</year><article-title>Dynamic expression of the pro-dopaminergic transcription factors Pax6 and Dlx2 during postnatal olfactory bulb neurogenesis</article-title><source>Frontiers in Cellular Neuroscience</source><volume>6</volume><elocation-id>6</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2012.00006</pub-id><pub-id pub-id-type="pmid">22371698</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doetsch</surname> <given-names>F</given-names></name><name><surname>Petreanu</surname> <given-names>L</given-names></name><name><surname>Caille</surname> <given-names>I</given-names></name><name><surname>Garcia-Verdugo</surname> <given-names>JM</given-names></name><name><surname>Alvarez-Buylla</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>EGF converts transit-amplifying neurogenic precursors in the adult brain into multipotent stem cells</article-title><source>Neuron</source><volume>36</volume><fpage>1021</fpage><lpage>1034</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(02)01133-9</pub-id><pub-id pub-id-type="pmid">12495619</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernández</surname> <given-names>ME</given-names></name><name><surname>Croce</surname> <given-names>S</given-names></name><name><surname>Boutin</surname> <given-names>C</given-names></name><name><surname>Cremer</surname> <given-names>H</given-names></name><name><surname>Raineteau</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Targeted electroporation of defined lateral ventricular walls: a novel and rapid method to study fate specification during postnatal forebrain neurogenesis</article-title><source>Neural Development</source><volume>6</volume><elocation-id>13</elocation-id><pub-id pub-id-type="doi">10.1186/1749-8104-6-13</pub-id><pub-id pub-id-type="pmid">21466691</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiorelli</surname> <given-names>R</given-names></name><name><surname>Azim</surname> <given-names>K</given-names></name><name><surname>Fischer</surname> <given-names>B</given-names></name><name><surname>Raineteau</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Adding a spatial dimension to postnatal ventricular-subventricular zone neurogenesis</article-title><source>Development</source><volume>142</volume><fpage>2109</fpage><lpage>2120</lpage><pub-id pub-id-type="doi">10.1242/dev.119966</pub-id><pub-id pub-id-type="pmid">26081572</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flames</surname> <given-names>N</given-names></name><name><surname>Pla</surname> <given-names>R</given-names></name><name><surname>Gelman</surname> <given-names>DM</given-names></name><name><surname>Rubenstein</surname> <given-names>JL</given-names></name><name><surname>Puelles</surname> <given-names>L</given-names></name><name><surname>Marín</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Delineation of multiple subpallial progenitor domains by the combinatorial expression of transcriptional codes</article-title><source>Journal of Neuroscience</source><volume>27</volume><fpage>9682</fpage><lpage>9695</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2750-07.2007</pub-id><pub-id pub-id-type="pmid">17804629</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furimsky</surname> <given-names>M</given-names></name><name><surname>Wallace</surname> <given-names>VA</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Complementary gli activity mediates early patterning of the mouse visual system</article-title><source>Developmental Dynamics</source><volume>235</volume><fpage>594</fpage><lpage>605</lpage><pub-id pub-id-type="doi">10.1002/dvdy.20658</pub-id><pub-id pub-id-type="pmid">16342201</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guillemot</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Spatial and temporal specification of neural fates by transcription factor codes</article-title><source>Development</source><volume>134</volume><fpage>3771</fpage><lpage>3780</lpage><pub-id pub-id-type="doi">10.1242/dev.006379</pub-id><pub-id pub-id-type="pmid">17898002</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hack</surname> <given-names>MA</given-names></name><name><surname>Saghatelyan</surname> <given-names>A</given-names></name><name><surname>de Chevigny</surname> <given-names>A</given-names></name><name><surname>Pfeifer</surname> <given-names>A</given-names></name><name><surname>Ashery-Padan</surname> <given-names>R</given-names></name><name><surname>Lledo</surname> <given-names>PM</given-names></name><name><surname>Götz</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Neuronal fate determinants of adult olfactory bulb neurogenesis</article-title><source>Nature Neuroscience</source><volume>8</volume><fpage>865</fpage><lpage>872</lpage><pub-id pub-id-type="doi">10.1038/nn1479</pub-id><pub-id pub-id-type="pmid">15951811</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hallonet</surname> <given-names>M</given-names></name><name><surname>Hollemann</surname> <given-names>T</given-names></name><name><surname>Wehr</surname> <given-names>R</given-names></name><name><surname>Jenkins</surname> <given-names>NA</given-names></name><name><surname>Copeland</surname> <given-names>NG</given-names></name><name><surname>Pieler</surname> <given-names>T</given-names></name><name><surname>Gruss</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Vax1 is a novel homeobox-containing gene expressed in the developing anterior ventral forebrain</article-title><source>Development</source><volume>125</volume><fpage>2599</fpage><lpage>2610</lpage><pub-id pub-id-type="pmid">9636075</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hallonet</surname> <given-names>M</given-names></name><name><surname>Hollemann</surname> <given-names>T</given-names></name><name><surname>Pieler</surname> <given-names>T</given-names></name><name><surname>Gruss</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Vax1, a novel homeobox-containing gene, directs development of the basal forebrain and visual system</article-title><source>Genes &amp; Development</source><volume>13</volume><fpage>3106</fpage><lpage>3114</lpage><pub-id pub-id-type="doi">10.1101/gad.13.23.3106</pub-id><pub-id pub-id-type="pmid">10601036</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffmann</surname> <given-names>HM</given-names></name><name><surname>Trang</surname> <given-names>C</given-names></name><name><surname>Gong</surname> <given-names>P</given-names></name><name><surname>Kimura</surname> <given-names>I</given-names></name><name><surname>Pandolfi</surname> <given-names>EC</given-names></name><name><surname>Mellon</surname> <given-names>PL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Deletion of Vax1 from Gonadotropin-Releasing hormone (GnRH) Neurons abolishes GnRH expression and leads to hypogonadism and infertility</article-title><source>Journal of Neuroscience</source><volume>36</volume><fpage>3506</fpage><lpage>3518</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2723-15.2016</pub-id><pub-id pub-id-type="pmid">27013679</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ihrie</surname> <given-names>RA</given-names></name><name><surname>Shah</surname> <given-names>JK</given-names></name><name><surname>Harwell</surname> <given-names>CC</given-names></name><name><surname>Levine</surname> <given-names>JH</given-names></name><name><surname>Guinto</surname> <given-names>CD</given-names></name><name><surname>Lezameta</surname> <given-names>M</given-names></name><name><surname>Kriegstein</surname> <given-names>AR</given-names></name><name><surname>Alvarez-Buylla</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Persistent sonic hedgehog signaling in adult brain determines neural stem cell positional identity</article-title><source>Neuron</source><volume>71</volume><fpage>250</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2011.05.018</pub-id><pub-id pub-id-type="pmid">21791285</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jessell</surname> <given-names>TM</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Neuronal specification in the spinal cord: inductive signals and transcriptional codes</article-title><source>Nature Reviews Genetics</source><volume>1</volume><fpage>20</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1038/35049541</pub-id><pub-id pub-id-type="pmid">11262869</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohwi</surname> <given-names>M</given-names></name><name><surname>Osumi</surname> <given-names>N</given-names></name><name><surname>Rubenstein</surname> <given-names>JL</given-names></name><name><surname>Alvarez-Buylla</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Pax6 is required for making specific subpopulations of granule and periglomerular neurons in the olfactory bulb</article-title><source>Journal of Neuroscience</source><volume>25</volume><fpage>6997</fpage><lpage>7003</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1435-05.2005</pub-id><pub-id pub-id-type="pmid">16049175</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname> <given-names>HC</given-names></name><name><surname>Seal</surname> <given-names>RP</given-names></name><name><surname>Johnson</surname> <given-names>JE</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Making sense out of spinal cord somatosensory development</article-title><source>Development</source><volume>143</volume><fpage>3434</fpage><lpage>3448</lpage><pub-id pub-id-type="doi">10.1242/dev.139592</pub-id><pub-id pub-id-type="pmid">27702783</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lledo</surname> <given-names>PM</given-names></name><name><surname>Merkle</surname> <given-names>FT</given-names></name><name><surname>Alvarez-Buylla</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Origin and function of olfactory bulb interneuron diversity</article-title><source>Trends in Neurosciences</source><volume>31</volume><fpage>392</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2008.05.006</pub-id><pub-id pub-id-type="pmid">18603310</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname> <given-names>MA</given-names></name><name><surname>Rossi</surname> <given-names>FM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Silencing inhibits Cre-mediated recombination of the Z/AP and Z/EG reporters in adult cells</article-title><source>PLOS ONE</source><volume>4</volume><elocation-id>e5435</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0005435</pub-id><pub-id pub-id-type="pmid">19415111</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lugert</surname> <given-names>S</given-names></name><name><surname>Basak</surname> <given-names>O</given-names></name><name><surname>Knuckles</surname> <given-names>P</given-names></name><name><surname>Haussler</surname> <given-names>U</given-names></name><name><surname>Fabel</surname> <given-names>K</given-names></name><name><surname>Götz</surname> <given-names>M</given-names></name><name><surname>Haas</surname> <given-names>CA</given-names></name><name><surname>Kempermann</surname> <given-names>G</given-names></name><name><surname>Taylor</surname> <given-names>V</given-names></name><name><surname>Giachino</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Quiescent and active hippocampal neural stem cells with distinct morphologies respond selectively to physiological and pathological stimuli and aging</article-title><source>Cell Stem Cell</source><volume>6</volume><fpage>445</fpage><lpage>456</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2010.03.017</pub-id><pub-id pub-id-type="pmid">20452319</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname> <given-names>L</given-names></name><name><surname>Ambrozkiewicz</surname> <given-names>MC</given-names></name><name><surname>Benseler</surname> <given-names>F</given-names></name><name><surname>Chen</surname> <given-names>C</given-names></name><name><surname>Dumontier</surname> <given-names>E</given-names></name><name><surname>Falkner</surname> <given-names>S</given-names></name><name><surname>Furlanis</surname> <given-names>E</given-names></name><name><surname>Gomez</surname> <given-names>AM</given-names></name><name><surname>Hoshina</surname> <given-names>N</given-names></name><name><surname>Huang</surname> <given-names>W-H</given-names></name><name><surname>Hutchison</surname> <given-names>MA</given-names></name><name><surname>Itoh-Maruoka</surname> <given-names>Y</given-names></name><name><surname>Lavery</surname> <given-names>LA</given-names></name><name><surname>Li</surname> <given-names>W</given-names></name><name><surname>Maruo</surname> <given-names>T</given-names></name><name><surname>Motohashi</surname> <given-names>J</given-names></name><name><surname>Pai</surname> <given-names>EL-L</given-names></name><name><surname>Pelkey</surname> <given-names>KA</given-names></name><name><surname>Pereira</surname> <given-names>A</given-names></name><name><surname>Philips</surname> <given-names>T</given-names></name><name><surname>Sinclair</surname> <given-names>JL</given-names></name><name><surname>Stogsdill</surname> <given-names>JA</given-names></name><name><surname>Traunmüller</surname> <given-names>L</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Wortel</surname> <given-names>J</given-names></name><name><surname>You</surname> <given-names>W</given-names></name><name><surname>Abumaria</surname> <given-names>N</given-names></name><name><surname>Beier</surname> <given-names>KT</given-names></name><name><surname>Brose</surname> <given-names>N</given-names></name><name><surname>Burgess</surname> <given-names>HA</given-names></name><name><surname>Cepko</surname> <given-names>CL</given-names></name><name><surname>Cloutier</surname> <given-names>J-F</given-names></name><name><surname>Eroglu</surname> <given-names>C</given-names></name><name><surname>Goebbels</surname> <given-names>S</given-names></name><name><surname>Kaeser</surname> <given-names>PS</given-names></name><name><surname>Kay</surname> <given-names>JN</given-names></name><name><surname>Lu</surname> <given-names>W</given-names></name><name><surname>Luo</surname> <given-names>L</given-names></name><name><surname>Mandai</surname> <given-names>K</given-names></name><name><surname>McBain</surname> <given-names>CJ</given-names></name><name><surname>Nave</surname> <given-names>K-A</given-names></name><name><surname>Prado</surname> <given-names>MAM</given-names></name><name><surname>Prado</surname> <given-names>VF</given-names></name><name><surname>Rothstein</surname> <given-names>J</given-names></name><name><surname>Rubenstein</surname> <given-names>JLR</given-names></name><name><surname>Saher</surname> <given-names>G</given-names></name><name><surname>Sakimura</surname> <given-names>K</given-names></name><name><surname>Sanes</surname> <given-names>JR</given-names></name><name><surname>Scheiffele</surname> <given-names>P</given-names></name><name><surname>Takai</surname> <given-names>Y</given-names></name><name><surname>Umemori</surname> <given-names>H</given-names></name><name><surname>Verhage</surname> <given-names>M</given-names></name><name><surname>Yuzaki</surname> <given-names>M</given-names></name><name><surname>Zoghbi</surname> <given-names>HY</given-names></name><name><surname>Kawabe</surname> <given-names>H</given-names></name><name><surname>Craig</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Optimizing nervous System-Specific gene targeting with cre driver lines: prevalence of germline recombination and influencing factors</article-title><source>Neuron</source><volume>106</volume><fpage>37</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2020.01.008</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merkle</surname> <given-names>FT</given-names></name><name><surname>Mirzadeh</surname> <given-names>Z</given-names></name><name><surname>Alvarez-Buylla</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Mosaic organization of neural stem cells in the adult brain</article-title><source>Science</source><volume>317</volume><fpage>381</fpage><lpage>384</lpage><pub-id pub-id-type="doi">10.1126/science.1144914</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morin</surname> <given-names>X</given-names></name><name><surname>Jaouen</surname> <given-names>F</given-names></name><name><surname>Durbec</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Control of planar divisions by the G-protein regulator LGN maintains progenitors in the chick neuroepithelium</article-title><source>Nature Neuroscience</source><volume>10</volume><fpage>1440</fpage><lpage>1448</lpage><pub-id pub-id-type="doi">10.1038/nn1984</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mui</surname> <given-names>SH</given-names></name><name><surname>Kim</surname> <given-names>JW</given-names></name><name><surname>Lemke</surname> <given-names>G</given-names></name><name><surname>Bertuzzi</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Vax genes ventralize the embryonic eye</article-title><source>Genes &amp; Development</source><volume>19</volume><fpage>1249</fpage><lpage>1259</lpage><pub-id pub-id-type="doi">10.1101/gad.1276605</pub-id><pub-id pub-id-type="pmid">15905411</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohsaki</surname> <given-names>K</given-names></name><name><surname>Morimitsu</surname> <given-names>T</given-names></name><name><surname>Ishida</surname> <given-names>Y</given-names></name><name><surname>Kominami</surname> <given-names>R</given-names></name><name><surname>Takahashi</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Expression of the vax family homeobox genes suggests multiple roles in eye development</article-title><source>Genes to Cells</source><volume>4</volume><fpage>267</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2443.1999.00257.x</pub-id><pub-id pub-id-type="pmid">10421837</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Platel</surname> <given-names>JC</given-names></name><name><surname>Angelova</surname> <given-names>A</given-names></name><name><surname>Bugeon</surname> <given-names>S</given-names></name><name><surname>Wallace</surname> <given-names>J</given-names></name><name><surname>Ganay</surname> <given-names>T</given-names></name><name><surname>Chudotvorova</surname> <given-names>I</given-names></name><name><surname>Deloulme</surname> <given-names>JC</given-names></name><name><surname>Béclin</surname> <given-names>C</given-names></name><name><surname>Tiveron</surname> <given-names>MC</given-names></name><name><surname>Coré</surname> <given-names>N</given-names></name><name><surname>Murthy</surname> <given-names>VN</given-names></name><name><surname>Cremer</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Neuronal integration in the adult mouse olfactory bulb is a non-selective addition process</article-title><source>eLife</source><volume>8</volume><elocation-id>e44830</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.44830</pub-id><pub-id pub-id-type="pmid">31294694</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sagner</surname> <given-names>A</given-names></name><name><surname>Briscoe</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Establishing neuronal diversity in the spinal cord: a time and a place</article-title><source>Development</source><volume>146</volume><elocation-id>dev182154</elocation-id><pub-id pub-id-type="doi">10.1242/dev.182154</pub-id><pub-id pub-id-type="pmid">31767567</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schindelin</surname> <given-names>J</given-names></name><name><surname>Arganda-Carreras</surname> <given-names>I</given-names></name><name><surname>Frise</surname> <given-names>E</given-names></name><name><surname>Kaynig</surname> <given-names>V</given-names></name><name><surname>Longair</surname> <given-names>M</given-names></name><name><surname>Pietzsch</surname> <given-names>T</given-names></name><name><surname>Preibisch</surname> <given-names>S</given-names></name><name><surname>Rueden</surname> <given-names>C</given-names></name><name><surname>Saalfeld</surname> <given-names>S</given-names></name><name><surname>Schmid</surname> <given-names>B</given-names></name><name><surname>Tinevez</surname> <given-names>JY</given-names></name><name><surname>White</surname> <given-names>DJ</given-names></name><name><surname>Hartenstein</surname> <given-names>V</given-names></name><name><surname>Eliceiri</surname> <given-names>K</given-names></name><name><surname>Tomancak</surname> <given-names>P</given-names></name><name><surname>Cardona</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fiji: an open-source platform for biological-image analysis</article-title><source>Nature Methods</source><volume>9</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id><pub-id pub-id-type="pmid">22743772</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soria</surname> <given-names>JM</given-names></name><name><surname>Taglialatela</surname> <given-names>P</given-names></name><name><surname>Gil-Perotin</surname> <given-names>S</given-names></name><name><surname>Galli</surname> <given-names>R</given-names></name><name><surname>Gritti</surname> <given-names>A</given-names></name><name><surname>Verdugo</surname> <given-names>JM</given-names></name><name><surname>Bertuzzi</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Defective postnatal neurogenesis and disorganization of the rostral migratory stream in absence of the Vax1 homeobox gene</article-title><source>Journal of Neuroscience</source><volume>24</volume><fpage>11171</fpage><lpage>11181</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3248-04.2004</pub-id><pub-id pub-id-type="pmid">15590934</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoykova</surname> <given-names>A</given-names></name><name><surname>Treichel</surname> <given-names>D</given-names></name><name><surname>Hallonet</surname> <given-names>M</given-names></name><name><surname>Gruss</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Pax6 modulates the dorsoventral patterning of the mammalian telencephalon</article-title><source>The Journal of Neuroscience</source><volume>20</volume><fpage>8042</fpage><lpage>8050</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.20-21-08042.2000</pub-id><pub-id pub-id-type="pmid">11050125</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taglialatela</surname> <given-names>P</given-names></name><name><surname>Soria</surname> <given-names>JM</given-names></name><name><surname>Caironi</surname> <given-names>V</given-names></name><name><surname>Moiana</surname> <given-names>A</given-names></name><name><surname>Bertuzzi</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Compromised generation of GABAergic interneurons in the brains of Vax1-/- mice</article-title><source>Development</source><volume>131</volume><fpage>4239</fpage><lpage>4249</lpage><pub-id pub-id-type="doi">10.1242/dev.01299</pub-id><pub-id pub-id-type="pmid">15280216</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Take-uchi</surname> <given-names>M</given-names></name><name><surname>Clarke</surname> <given-names>JD</given-names></name><name><surname>Wilson</surname> <given-names>SW</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Hedgehog signalling maintains the optic stalk-retinal interface through the regulation of vax gene activity</article-title><source>Development</source><volume>130</volume><fpage>955</fpage><lpage>968</lpage><pub-id pub-id-type="doi">10.1242/dev.00305</pub-id><pub-id pub-id-type="pmid">12538521</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiveron</surname> <given-names>M-C</given-names></name><name><surname>Hirsch</surname> <given-names>M-R</given-names></name><name><surname>Brunet</surname> <given-names>J-F</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>The expression pattern of the transcription factor Phox2 delineates synaptic pathways of the autonomic nervous system</article-title><source>The Journal of Neuroscience</source><volume>16</volume><fpage>7649</fpage><lpage>7660</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.16-23-07649.1996</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiveron</surname> <given-names>MC</given-names></name><name><surname>Beclin</surname> <given-names>C</given-names></name><name><surname>Murgan</surname> <given-names>S</given-names></name><name><surname>Wild</surname> <given-names>S</given-names></name><name><surname>Angelova</surname> <given-names>A</given-names></name><name><surname>Marc</surname> <given-names>J</given-names></name><name><surname>Coré</surname> <given-names>N</given-names></name><name><surname>de Chevigny</surname> <given-names>A</given-names></name><name><surname>Herrera</surname> <given-names>E</given-names></name><name><surname>Bosio</surname> <given-names>A</given-names></name><name><surname>Bertrand</surname> <given-names>V</given-names></name><name><surname>Cremer</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Zic-Proteins are repressors of dopaminergic forebrain fate in mice and <italic>C. elegans</italic></article-title><source>The Journal of Neuroscience</source><volume>37</volume><fpage>10611</fpage><lpage>10623</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3888-16.2017</pub-id><pub-id pub-id-type="pmid">28972122</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ventura</surname> <given-names>RE</given-names></name><name><surname>Goldman</surname> <given-names>JE</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Dorsal radial Glia generate olfactory bulb interneurons in the postnatal murine brain</article-title><source>Journal of Neuroscience</source><volume>27</volume><fpage>4297</fpage><lpage>4302</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0399-07.2007</pub-id><pub-id pub-id-type="pmid">17442813</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinandy</surname> <given-names>F</given-names></name><name><surname>Ninkovic</surname> <given-names>J</given-names></name><name><surname>Götz</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Restrictions in time and space--new insights into generation of specific neuronal subtypes in the adult mammalian brain</article-title><source>European Journal of Neuroscience</source><volume>33</volume><fpage>1045</fpage><lpage>1054</lpage><pub-id pub-id-type="doi">10.1111/j.1460-9568.2011.07602.x</pub-id><pub-id pub-id-type="pmid">21395847</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitman</surname> <given-names>MC</given-names></name><name><surname>Greer</surname> <given-names>CA</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Adult-generated neurons exhibit diverse developmental fates</article-title><source>Developmental Neurobiology</source><volume>67</volume><fpage>1079</fpage><lpage>1093</lpage><pub-id pub-id-type="doi">10.1002/dneu.20389</pub-id><pub-id pub-id-type="pmid">17565001</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitman</surname> <given-names>MC</given-names></name><name><surname>Greer</surname> <given-names>CA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Adult neurogenesis and the olfactory system</article-title><source>Progress in Neurobiology</source><volume>89</volume><fpage>162</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1016/j.pneurobio.2009.07.003</pub-id><pub-id pub-id-type="pmid">19615423</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>L</given-names></name><name><surname>Saitsu</surname> <given-names>H</given-names></name><name><surname>Sun</surname> <given-names>X</given-names></name><name><surname>Shiota</surname> <given-names>K</given-names></name><name><surname>Ishibashi</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Sonic hedgehog is involved in formation of the ventral optic cup by limiting Bmp4 expression to the dorsal domain</article-title><source>Mechanisms of Development</source><volume>127</volume><fpage>62</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1016/j.mod.2009.10.006</pub-id><pub-id pub-id-type="pmid">19854269</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.58215.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Liberles</surname><given-names>Stephen</given-names></name><role>Reviewing Editor</role><aff><institution>Harvard Medical School</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>The olfactory bulb is a rare brain region that incorporates newly born neurons in the adult. The molecular pathways that give rise to the diversity of olfactory bulb neuron types during adult neurogenesis are poorly understood. This study reveals a key role for the transcription factor <italic>Vax1</italic> in guiding cell fate decisions of adult-born neurons, promoting formation of calbindin interneurons and suppressing formation of dopaminergic neurons.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Regulatory interactions between <italic>Vax1</italic>, <italic>Pax6</italic> and <italic>miR-7</italic> regionalize the lateral SVZ during mice olfactory bulb neurogenesis&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Gary Westbrook as the Senior Editor. The reviewers have opted to remain anonymous. The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>As the editors have judged that your manuscript is of interest, but that additional experiments are required before it is published, we would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). First, because many researchers have temporarily lost access to the labs, we will give authors as much time as they need to submit revised manuscripts. We are also offering, if you choose, to post the manuscript to bioRxiv (if it is not already there) along with this decision letter and a formal designation that the manuscript is &quot;in revision at <italic>eLife</italic>&quot;. Please let us know if you would like to pursue this option. (If your work is more suitable for medRxiv, you will need to post the preprint yourself, as the mechanisms for us to do so are still in development.)</p><p>Summary:</p><p>Neurons in the olfactory bulb are replenished throughout life, but mechanisms underlying the maintenance of neuronal diversity remain poorly defined. In this study, the authors identify a key role for <italic>Vax1</italic> and <italic>Pax6</italic> in the cell fate decisions that control differentiation of particular olfactory bulb interneurons.</p><p>Essential revisions:</p><p>– Data implicating a functional role for <italic>Mir-7</italic> are preliminary; it is advised that claims be bolstered or toned down.</p><p>– Comments from all reviewers are provided below in case they are helpful. Reviewer #3 in particular requested additional data and information prior to rendering a final decision.</p><p><italic>Reviewer #1:</italic></p><p>Core et al. study the transcription factor <italic>Vax1</italic> in the context of cell fate using the SVZ-RMS-OB adult neurogenesis model. The novel part of the data seems incremental and while suggestive it's not always compelling; Particularly so the claims of specificity. Some analyses and controls could be improved.</p><p>1) Figure 1 – The combination of ISH and IC is legitimate but the data are not compelling. The overlap in Figure 1G-H are good examples. This is also evident in the qualitative description of overlap. In any event, these data are not very clean. The paper would benefit from a quantitative approach. For example, a double-labeling smFISH expression analysis would be more successful.</p><p>2) Figure 2 – The comparison of GCL tdt+ numbers (Figure 2 B,C ) should be compared to PGL numbers. The current comparison to 2D,E is not a fair comparison (apples to apples…). For claim a specificity effect, they should compare to other cell types in the PGL in the same animals.</p><p>3) Figure 3D – The large scale gradient is convincing but not very novel. To drive this conclusion home, a similar analysis that is done in 3A should be conducted at a single cell level.</p><p>In C-F the claim for specificity is weak. They should show that expression of other TFs are not hampered in the GFP cells. It’s possible that the mere over expression of a <italic>Vax1</italic> impacts other proteins in a negative way. I am not from the field but it seems to me that a better control is needed (e.g. at the very least a scrambled version of Vax1OE).</p><p>4) Figure 4 – in 4B the CR distribution seems to be different – it has a double peak as compared to controls. More appropriate statistics may show this difference.</p><p>4I distributions are very similar. The text description of these as being marginally significant is misleading.</p><p>5) The <italic>miR-7</italic> data are robust but remain anecdotal and currently not very natural to add it to the storyline of the paper that remains intact without it.</p><p><italic>Reviewer #2:</italic></p><p>The manuscript by Core et al. examines the molecular players that display spatial segregation and regulate neonatal progenitor fate from the SVZ to the olfactory bulb. They build on previous work from their lab and others that have reported specific function of <italic>PAx6</italic> and <italic>mir-7</italic> in neuron fate determination. The manuscript is well-written and uses an array of approaches to address their questions. Overall, the data are strong and well presented. My enthusiasm is to some extent limited as outlined in the following comments:</p><p>1) Data regarding the contribution of <italic>miR-7</italic> are limited. I think more data are either necessary to show that <italic>Vax1</italic> works through <italic>mir-7</italic> to regulate neuronal fate or the authors should change their writing and conclusion.</p><p>For example, in the Abstract: &quot;We provide evidence that this repression occurs via activation of microRNA <italic>miR-7</italic>, targeting <italic>Pax6</italic> mRNA.&quot; I think it is overselling the data presented in this manuscript. Much more data would be required for this conclusion. For example, the <italic>mir-7</italic> data could be left out of the Abstract but presented at the end of the Introduction as well as discussed.</p><p>2) Figure 1: please show analysis of the in situ/immune data.</p><p>3) Better images for Figure 3C would be helpful to actually see the decrease in <italic>Pax6</italic> intensity.</p><p>4) The sentence: &quot;However, we stably observed a tendency for an increase over independent electroporation experiments (3 experiments for each condition with a total of 12 animals/ condition, Figure 4I).&quot; should be removed. There is no effect.</p><p><italic>Reviewer #3:</italic></p><p>During the process of brain development in mammals, neuronal fates are determined by the combinatorial expression of transcription factors. In the olfactory bulb (OB), different subsets of interneurons are constantly supplied from the subventricular zone (SVZ) not only in neonates but also during adulthood. These OB interneurons demonstrate a wide variety of phenotypes in morphology, migration, connectivity, and the use of neurotransmitters. It has been shown that this diversity of interneurons is generated depending on the stem-cell microdomains along the walls of lateral ventricles. In this study, the authors tried to clarify the molecular mechanism underlying the positional identity of neural stem-cells by analyzing gene expression during postnatal OB neurogenesis.</p><p>Using the conditional knockout of a homeodomain protein, Vax1, as well as the in vivo electroporation of the Vax1-expression vector, the authors demonstrated new findings that provide fundamental insights into the cross-regulatory interactions that determine neuronal phenotypes in the mammalian brain. Major findings in this study are: 1) Vax1 is a key determinant for the generation of Calbindin-positive interneurons in the ventral compartment of the SVZ; 2) Vax1 negatively regulates the transcription of Pax6 whose expression is essential for the generation of dopaminergic neurons in the dorsal compartment; and 3) Repression of Pax6 occurs by microRNA <italic>miR-7</italic> targeting the Pax6 mRNA.</p><p>These findings are novel and will provide new insights into our understanding of fate determination of developing neurons. The paper is clearly written and easy to understand. Experiments in this study are elegantly designed. I therefore support publication of this manuscript in <italic>eLife</italic> if the reviewer's comments are properly responded.</p><p>Specific comments:</p><p>1) In the loss-of-function experiment in Figure 2, it would be helpful if the authors could show how efficiently Vax1 expression is suppressed in the targeted tdTomato positive cells by using in situ hybridization.</p><p>2) Also in the gain-of-function experiment in Figure 3, the levels of Vax1 derived from the electroporated vector DNA should be shown for the GFP-positive cells, by in situ hybridization.</p><p>3) In this manuscript, the authors analyzed regulatory interactions among Vax1, Pax6, and <italic>miR-7</italic> only in neonates. Since interneurons are constantly regenerated during adulthood, it would be helpful, if the authors could demonstrate the data showing that the same regulatory cross-talk can be seen in the adult neurogenesis of interneurons.</p><p>4) What is the mechanism of Vax1-mediated <italic>miR-7</italic> enhancement? Do they directly interact with each other? Is there any binding site for Vax1 within the promoter region of the <italic>miR-7</italic> gene?</p><p>5) Cross-regulatory interactions for <italic>Vax1</italic>, <italic>Pax6</italic>, and <italic>miR-7</italic> are nicely shown in this study. It would be helpful if the authors could discuss this regulation strategy in the context of neurogenesis during brain development in order for the paper to attract a wider research audience other than those investigating transcription factors.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.58215.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Reviewer #1:</p><p>1) Figure 1 – The combination of ISH and IC is legitimate but the data are not compelling. The overlap in Figure 1G-H are good examples. This is also evident in the qualitative description of overlap. In any event, these data are not very clean. The paper would benefit from a quantitative approach. For example, a double-labeling smFISH expression analysis would be more successful.</p></disp-quote><p>We quantified the percentage of double stained cells for the different markers used in Figure 1 D-F. Moreover, in the RMS (Figure 1 G,H) cells migrate partially intermingled, making a graded distribution of <italic>Vax1</italic> and <italic>Pax6</italic> positive cells, as is obvious in the SVZ, less evident. We added higher magnification images to illustrate the differential expression of <italic>Vax1</italic> in the ventral (Figure 1G’) and dorsal (Figure 1G’’) aspects of the RMS. We also added higher magnifications to illustrate the co-expression of DLX2 and <italic>Vax1</italic> in the RMS (Figure 1H’ and H’’). The Results section was changed accordingly.</p><disp-quote content-type="editor-comment"><p>2) Figure 2 – The comparison of GCL tdt+ numbers (Figure 2 B,C ) should be compared to PGL numbers. The current comparison to 2D,E is not a fair comparison (apples to apples…). For claim a specificity effect, they should compare to other cell types in the PGL in the same animals.</p></disp-quote><p>New data showing the PGC quantification was added to the manuscript as Figure 2—figure supplement 1B. Please also note that, in addition to the CB+ PGC population now presented in Figure 2E, we already analyzed in the same animals the number of TH<sup>+</sup> PGC (Figure 4I).</p><disp-quote content-type="editor-comment"><p>3) Figure 3D – The large scale gradient is convincing but not very novel. To drive this conclusion home, a similar analysis that is done in 3A should be conducted at a single cell level.</p><p>In C-F the claim for specificity is weak. They should show that expression of other TFs are not hampered in the GFP cells. It’s possible that the mere over expression of a Vax1 impacts other proteins in a negative way. I am not from the field but it seems to me that a better control is needed (e.g. at the very least a scrambled version of Vax1OE).</p></disp-quote><p>Here, the reviewer’s comments/questions are in part a bit unclear to us and we hope we got the main points.</p><p>To our knowledge the existence of large-scale gradients in the postnatal SVZ is still a relatively new concept. Designing and performing a single cell analysis experiment that provides reliable information about such gradients is not easy and, to our eyes, exceeds the scope of this study. Use of a scrambled protein as control for gain-of-function experiments in vivo is a rather unusual approach in the field. As far as we know, such a control has so far not been applied. Finally, specific <italic>Pax6</italic>/<italic>Vax1</italic> regulatory interactions have been shown in other brain developmental contexts, like for example the eye, arguing for the specificity of the observed effects here.</p><disp-quote content-type="editor-comment"><p>4) Figure 4 – in 4B the CR distribution seems to be different – it has a double peak as compared to controls. More appropriate statistics may show this difference.</p><p>4I distributions are very similar. The text description of these as being marginally significant is misleading.</p></disp-quote><p>Concerning 4b: We agree that there is some heterogeneity in this specific experiment. However, all samples have been treated exactly the same way and analyzed by the appropriate statistical tests. We do not see which variables can be tested to address the reviewers point.</p><p>Concerning Figure 4I: We accept the reviewer’s critique and removed any potentially misleading conclusion concerning these data from the Results section.</p><disp-quote content-type="editor-comment"><p>5) The miR-7 data are robust but remain anecdotal and currently not very natural to add it to the storyline of the paper that remains intact without it.</p></disp-quote><p>We added additional data, reinforcing the link between <italic>Vax1</italic> and <italic>miR-7</italic>, by showing the all three <italic>miR-7</italic> promoters contain putative <italic>Vax1</italic> binding sites. We opted to maintain the data in the manuscript, but tempered our conclusions concerning this aspect. We also removed the mention of <italic>miR-7</italic> from the manuscript title.</p><disp-quote content-type="editor-comment"><p>Reviewer #2:</p><p>1) Data regarding the contribution of miR-7 are limited. I think more data are either necessary to show that Vax1 works through mir-7 to regulate neuronal fate or the authors should change their writing and conclusion.</p><p>For example, in the Abstract: &quot;We provide evidence that this repression occurs via activation of microRNA miR-7, targeting Pax6 mRNA.&quot; I think it is overselling the data presented in this manuscript. Much more data would be required for this conclusion. For example, the mir-7 data could be left out of the Abstract but presented at the end of the Introduction as well as discussed.</p></disp-quote><p>We accept the reviewer’s critique and react threefold. First, we provide new data showing that all three <italic>miR-7</italic> promoters contain putative <italic>Vax1</italic> binding sites. Second, we tempered our conclusions concerning the <italic>Vax1</italic>-<italic>miR-7</italic> link in the Abstract and the main manuscript. Third, we removed the term <italic>miR-7</italic> from the title.</p><disp-quote content-type="editor-comment"><p>2) Figure 1: please show analysis of the in situ/immune data.</p></disp-quote><p>As requested, we included quantifications of the in situ/immune staining’s. The data are now presented in the Results section.</p><disp-quote content-type="editor-comment"><p>3) Better images for Figure 3C would be helpful to actually see the decrease in Pax6 intensity.</p></disp-quote><p>We added new images illustrating the downregulation of <italic>Pax6</italic> protein after <italic>Vax1</italic> electroporation. The new data are now presented as Figure 3D.</p><disp-quote content-type="editor-comment"><p>4) The sentence: &quot;However, we stably observed a tendency for an increase over independent electroporation experiments (3 experiments for each condition with a total of 12 animals/ condition, Figure 4I).&quot; should be removed. There is no effect.</p></disp-quote><p>We agree and removed the phrase from the Results section of manuscript.</p><disp-quote content-type="editor-comment"><p>Reviewer #3:</p><p>1) In the loss-of-function experiment in Figure 2, it would be helpful if the authors could show how efficiently Vax1 expression is suppressed in the targeted tdTomato positive cells　by using in situ hybridization.</p></disp-quote><p>To address the efficiency of CRE mediated recombination we expressed the recombinase by in vivo electroporation in control and <italic>Vax1</italic>/Ai14 double mutants and isolated transfected tdTomato-positive cells by FACS. The quantitative RT-PCR results, now shown in Figure 2—figure supplement 1, clearly show a massive reduction in <italic>Vax1</italic> mRNA levels after CRE expression, demonstrating efficient recombination.</p><p>This approach was necessary as in light of the relatively small number of transfected cells after in vivo electroporation – and facing the cellular complexity of the postnatal SVZ- in situ hybridization is not suited to give a quantitative notion of gene-knockout.</p><disp-quote content-type="editor-comment"><p>2) Also in the gain-of-function experiment in Figure 3, the levels of Vax1 derived from the electroporated vector DNA should be shown for the GFP-positive cells, by in situ hybridization.</p></disp-quote><p>As for the knockout, we combined electroporation, here of an overexpression plasmid, with FACS and qRT-PCR. We found the expected large increase in <italic>Vax1</italic> mRNA levels in the GFP positive fraction. This control is shown in Figure 5B.</p><disp-quote content-type="editor-comment"><p>3) In this manuscript, the authors analyzed regulatory interactions among Vax1, Pax6, and miR-7 only in neonates. Since interneurons are constantly regenerated during adulthood, it would be helpful, if the authors could demonstrate the data showing that the same regulatory cross-talk can be seen in the adult neurogenesis of interneurons.</p></disp-quote><p>In previous work we demonstrated that the dorsoventral <italic>Pax6</italic> and the ventrodorsally oriented <italic>miR-7</italic> gradients are maintained in adult stages (de Chevigny et al., 2012b, Supplemental Figures 1 and 4). Here, we show now, as the new</p><p>Figure 3—figure supplement 1, that the postnatal ventrodorsally oriented <italic>Vax1</italic> gradient is also maintained in the adult, allowing to speculate that the mechanism remains active. This new data on adult <italic>Vax1</italic> expression is now mentioned and discussed in the manuscript.</p><p>It would of course be tempting to test the validity of the <italic>Vax1</italic>/<italic>Pax6</italic>/<italic>miR-7</italic> interactions in adults. However, in vivo electroporation in adults is far less efficient than in the postnatal, leading only to low amounts of transfected cells in the OB. As our analyses depend on precise quantification of large numbers of cells in gain- and loss of-function experiments, meaningful data cannot be expected from such approaches.</p><p>Viral transduction, that is normally used in adults, cannot be targeted to specific subregions of the SVZ. It appears conceivable to design complex transgenic approaches to target specific SVZ compartments with CRE, but such experiments, if possible, would represent a long-term project on its own that exceeds what can be done here. We hope this is acceptable.</p><disp-quote content-type="editor-comment"><p>4) What is the mechanism of Vax1-mediated miR-7 enhancement? Do they directly interact with each other? Is there any binding site for Vax1 within the promoter region of the miR-7 gene?</p></disp-quote><p>Following the reviewer’s suggestion, we investigated the presence of <italic>Vax1</italic> binding sites in the <italic>miR-7</italic> regulatory regions. Indeed, we found such sites in all three <italic>miR-7</italic> promoters, in agreement with a potential direct regulation. This new data are now presented in Figure 5D.</p><disp-quote content-type="editor-comment"><p>5) Cross-regulatory interactions for Vax1, Pax6, and miR-7 are nicely shown in this study. It would be helpful if the authors could discuss this regulation strategy in the context of neurogenesis during brain development in order for the paper to attract a wider research audience other than those investigating transcription factors.</p></disp-quote><p>To place our results in a wider context, we discuss now the OLIG2/Irx3/miR-17-3p regulatory network, that is used to define progenitor domains in the developing spinal cord.</p></body></sub-article></article>